Skip to main content
PLOS One logoLink to PLOS One
. 2021 Aug 2;16(8):e0234286. doi: 10.1371/journal.pone.0234286

Epidemiological study on foot-and-mouth disease in small ruminants: Sero-prevalence and risk factor assessment in Kenya

Eunice C Chepkwony 1, George C Gitao 2, Gerald M Muchemi 3, Abraham K Sangula 1, Salome W Kairu-Wanyoike 4,*
Editor: Jagadeesh Bayry5
PMCID: PMC8328338  PMID: 34339447

Abstract

Foot-and-mouth disease (FMD) is endemic in Kenya affecting cloven-hoofed ruminants. The epidemiology of the disease in small ruminants (SR) in Kenya is not documented. We carried out a cross-sectional study, the first in Kenya, to estimate the sero-prevalence of FMD in SR and the associated risk factors nationally. Selection of animals to be sampled used a multistage cluster sampling approach. Serum samples totaling 7564 were screened for FMD antibodies of non-structural-proteins using ID Screen® NSP Competition ELISA kit. To identify the risk factors, generalized linear mixed effects (GLMM) logistic regression analysis with county and villages as random effect variables was used. The country animal level sero-prevalence was 22.5% (95% CI: 22.3%-24.3%) while herd level sero-prevalence was 77.6% (95% CI: 73.9%-80.9%). The risk factor that was significantly positively associated with FMD sero-positivity in SR was multipurpose production type (OR = 1.307; p = 0.042). The risk factors that were significantly negatively associated with FMD sero-positivity were male sex (OR = 0.796; p = 0.007), young age (OR = 0.470; p = 0.010), and sedentary production zone (OR = 0.324; p<0.001). There were no statistically significant intra class correlations among the random effect variables but interactions between age and sex variables among the studied animals were statistically significant (p = 0.019). This study showed that there may be widespread undetected virus circulation in SR indicated by the near ubiquitous spatial distribution of significant FMD sero-positivity in the country. Strengthening of risk-based FMD surveillance in small ruminants is recommended. Adjustment of husbandry practices to control FMD in SR and in-contact species is suggested. Cross-transmission of FMD and more risk factors need to be researched.

Introduction

Livestock husbandry in developing countries like Kenya is critical for ensuring food security and for poverty alleviation [1]. Livestock are a source of meat, milk, hides and compost manure as well as an insurance against emergencies [13]. Sheep and goats (small ruminants) are sometimes preferred by farmers compared to large ruminants because of the small space they occupy and less fodder requirement. In addition, goats have high adaptability to harsh climates which makes them suitable for husbandry in marginal areas [2, 3]. Small ruminant population in Kenya stands at 17.1 million sheep, 27.7 million goats about 50–57% of which are in the pastoral and agro-pastoral production areas [4, 5]. Sheep breeds include red maasai, black-head Persian and east African fat tailed sheep. Among goats, the small east African is most dominant although milk breeds such as the Galla and Toggenberg are also to be found [6].

Infectious diseases constrain small ruminant (SR) production [7]. The S1 Table shows the sero-prevalence to FMD in small ruminants and associated risk factors that have been reported in various countries [821]. Therefore, in East African countries, FMD sero-prevalence in SR of between 4.0% and 48.5% has been reported. The risk factors that have been associated with FMD sero-positivity in SR in these countries are agro-ecology, production system, age, sex, contact with wildlife, season, breed, interaction with other livestock species, herd size, acquisition of livestock and husbandry practices [8, 9, 15, 18, 19, 20, 21].

Foot and mouth disease (FMD) is an acute highly contagious, transboundary, disease caused by foot and mouth disease virus (FMDV). It affects cloven-hoofed domestic ruminants and pigs, as well as wild ruminants [22]. It severely affects livestock production leading to disruption of trade in animals and their products at regional and international level. A global strategy for the control of FMD was endorsed in 2012 to minimize the burden of FMD in endemic settings and maintain free status in FMD-free countries [23].

The FMDV is classified into the Picornaviridae family and the genus Apthovirus. It is a small non-enveloped virus with an encoder for four structural proteins and ten nonstructural proteins [24]. The disease is among the World Organisation for Animal Health (OIE) listed diseases requiring immediate reporting and investigation in order to control its spread [23].

The incubation period for foot-and-mouth disease is 3–8 days in small ruminants [25]. The disease is characterized by high fever within two to three days, formation of vesicles and erosions inside the mouth leading to drooling of saliva. Vesicles are also on the nose, teats and when on the feet may rupture and cause lameness. It also causes several months of weight loss in adults and significant temporary or permanent reduction in milk production [26]. In sheep the disease persists for up to nine months and in goats for up to six months [27]. Foot and mouth disease in adult sheep and goats is frequently asymptomatic, but can cause high mortality in young animals. Clinical disease in young lambs and kids is characterized by death without the appearance of vesicles, due to heart failure following myocarditis [28]. Lameness is often characterized by unwillingness to rise and move [25, 29]. The disease can easily be missed unless individual animals are carefully examined for disease lesions. Small ruminants can therefore be responsible for the introduction of FMD into previously disease-free herds [30].

Although FMD may be suspected based on clinical signs and post-mortem findings, it cannot be differentiated clinically from other vesicular diseases [26]. Confirmation of any suspected FMD case through laboratory tests is therefore essential. Detection of the antibodies against the non-structural proteins (NSPs) of FMDV is used for differentiation between infected and vaccinated animals (DIVA) which is of great importance in the FMD control program. The 3ABC competition antibody ELISA which has high sensitivity and specificity can deliver same-day results when using the short protocol and is routinely applied for general screening for FMD [31, 32].

Foot and mouth disease is endemic in Kenya with outbreaks in cattle and serotype O has been the most prevalent serotype. Intermittent circulation of FMDV serotypes A, SAT 1 and SAT 2 have also been confirmed in various parts of the country in the last five years [33]. The main FMD control strategies in the country focus on vaccination of cattle. Although small ruminants are also affected by FMD and are herded together with cattle, they are not usually vaccinated [34].

Some studies have been carried out on FMD in cattle and buffaloes but no studies on the prevalence and associated risk factors in small ruminants have been done in Kenya. This study investigated the sero-prevalence and potential risk factors associated with FMD in domestic small ruminants in Kenya.

Materials and methods

The study population

The study was a cross-sectional one which targeted the national small ruminant population in Kenya. Kenya is made up of 47 counties. However, the objective was not to primarily measure the sero-prevalence per county but rather per the major small ruminant production zones. The sampling unit was the smallest administrative unit in record, the village, which was selected after first selecting the second smallest administrative unit, the sub-location. The sampling frame of sub-locations was available from the Kenya 2009 population and housing census [5].

Description of the study area

Broadly, Kenya can be divided into three ecological zones namely humid, semi-arid and arid areas. About 80% of the country is arid and semi-arid (ASAL) while the humid ecosystem occupies the remaining 20% of the country. The semi-arid areas normally experience short rainfall with prolonged drought while arid areas have long cyclic droughts, thus affecting pasture and water availability. The humid areas have long rain seasons with heavy down pours reaching 2700mm [35].

The main small ruminant production systems are pastoralism and agro-pastoralism as well as sedentary/mixed systems. Pastoral systems are in the arid and semi-arid climate zones where about 14 million people are dependent on livestock [36, 37]. Agro-pastoralism, is livestock production which is associated with dryland or rain-fed cropping and animals range over short distances. The average herd size of sheep and goat in pastoralist systems is estimated at 24.9 and 75.2 respectively [38]. Sedentary/mixed systems are found in the semi-arid, sub-humid, humid and highland zones. This farming system is based on livestock but practiced in proximity to, or perhaps in functional association with, other farming systems based on cropping or is a livestock subsystem of integrated crop-livestock farming. The average herd size of sheep and goats in this system is rarely reported but ranges between three and 10 [4, 37, 39]

Study design and methods

Sample size determination

For the purpose of this study, the country was divided into two zones; the pastoral zone (PZ) and the sedentary zone (SZ) as in Fig 1. Sample size calculation was in two stages: number of herds to be sampled and then number of animals to be sampled per herd. A herd included a group of sheep and goats in a farm and animals from neighbouring farms which came into contact (in-contact farms). The formula used was that by Humphry et al [40]. The assumptions that were made were: number of herds >10,000 in each zone; confidence level = 95%; accepted margin of error = 5%; expected proportion of positive herds in the population = 70% (expert opinion, confirmed now by Ahmed et al [41]; intra-class correlation coefficient (measure of variation between clusters) = 0.1 [42]; design effect = 2 [43]; test specificity = 99% [23]; test sensitivity = 100% [23]. The calculated sample size was 323 x design effect (2) = 646 herds countrywide. The minimum number of animals to be sampled per herd was determined as summarized in Cannon and Roe table cited by Thrusfield (p.239) [44]. This was determined making the following assumptions: expected prevalence of FMD in the herd = 20%; which was an average of two consecutive years in Tanzania [19]; confidence level = 95%; average herd size = 100. This yielded a sample size of 13 animals per herd which was increased to 14 to take care of any possible losses. Countrywide therefore, 646 herds resulting from one village per sub-location and one herd per village (or more if necessary to obtain sufficient animals) and 14 animals per herd yielded a sample size of 646 x 14 = 9044 samples. The two zones are quite distinct in structure even if FMD dynamics (in cattle) seem not very different. The SZ has small counties with very many sub-locations while the PZ has large counties with fewer sub-locations which could have led to over sampling in the SZ and low sampling in the PZ. It was also important to see the difference in the two zones and for this reason we chose to have a complete separation between the two and sample equal number of sub-locations (323) and therefore number of samples (4522) in each zone.

Fig 1. Study zones and selected sampling sites for the cross-sectional survey, Kenya, 2016.

Fig 1

Sampling of herds and animals

The sampling frame consisted of the 6796 sub-locations, as obtained from the national census of 2009 [5]. The sampling frame was used to randomly select the sub-locations to be sampled. However, sub-locations can be quite large and therefore once in the field the teams obtained the list of villages in the sub-locations and randomly selected villages within the sub-locations. A herd was then considered as all animals within the village from which the individual animals sampled were randomly selected. If one herd could yield all the animals required, only that herd was sampled, otherwise additional herds close to the selected herd were sampled until the required number to be sampled in the sub-location was reached. Therefore, a multistage cluster sampling was employed to select the animals from the two zones.

Data and serum sample collection

Data were collected using questionnaires and as laboratory results while serum samples were collected from eligible herds throughout the country.

Serum sample collection. Serum samples were collected by 15 teams of trained laboratory technicians under the supervision of a veterinarian. Sheep and goats aged six months and above were sampled to avoid those with maternal antibodies [45]. Age was determined by examining the dentition of each animal and information from the owner for young animals with no permanent incisors [46]. In the sampling stage animal level variables (biodata) were collected into a sampling form (S1 File) and included species (ovine or caprine), breed, age and the sex of the animal and origin (whether born in herd or brought in). The blood samples were collected from a jugular vein, using 10 ml sterile vacutainer tubes and gauge 21 needles and labeled with a unique identification (county code/sub-location/animal number/sex/age). The samples were then allowed to clot in cool-boxes. Once the blood clot had retracted after 12 to 24 hours the vials were centrifuged in the laboratories in the field to obtain serum which was placed in two 2ml cryovials (two aliquots) labeled with corresponding identification codes. In areas where laboratories or centrifuges were unavailable, serum was separated using sterile disposable pipettes (one per sample) and transferred into the cryovials. Samples were stored at -20°C in freezers located in the areas sampled in the field until the end of the sampling period (which was not more than 20 days per team) and were transported on ice using cool-boxes to the Central Veterinary Laboratories (CVL), Kabete, Kenya. At the CVL, the samples were held at -86°C until testing after which they were placed in a serum bank at the same temperature. Sample collection was part of a larger national survey for Rift Valley Fever (RVF) and Peste de Petits Ruminants (PPR) antibodies in small ruminants under a project titled “Improving Animal Disease Surveillance in Support of Trade in IGAD Member States”, in short “Surveillance of Trade Sensitive Diseases–STSD”. One aliquot was used to test for the presence or absence of antibodies for Rift Valley Fever (RVF) and Peste de Petits Ruminants (PPR) antibodies according to the objective of the STSD project. The second aliquot was moved to the FMD National Laboratory, Embakasi, Kenya and stored at -20°C until laboratory investigation for FMD antibodies.

Questionnaire administration. A pre-tested semi-structured questionnaire (S1 File) was administered in-person by trained enumerators to owners of sampled herds following the guidelines (S1 File) at the time of sample collection for collection of herd-level variables. Herd-level variables were production zone, whether the herd owners brought in animals in the last one year, whether the herd owners purchased animals from the market/middlemen, interaction with wildlife, production type, production system, housing type, grazing system, watering system, breeding method and altitude/elevation. Also based on Geographic Positioning System (GPS) technology, GPS coordinates and elevations were recorded for each herd location and this information was recorded in each questionnaire form which was labeled with the unique herd identification code.

Laboratory sample analysis

Individual animal serum samples were analysed using the foot and mouth disease virus 3 ABC- ELISA ID Screen® FMD NSP Competition kit (ID-VET, Grabels, France) to detect specific antibodies against the non-structural protein (NSP) of FMDV regardless of sero-type. This was done according to the manufacturer’s protocol. The test has specificity of 99% and sensitivity of 100% [23]. A herd was considered as positive if one or more animals in the herd were seropositive.

Data management and analysis

Individual animal laboratory data generated during testing along with individual animal biodata data obtained during sample collection (species, breed, sex, age, origin) were entered in Microsoft Excel 2010 spreadsheet. Questionnaire data which included mainly herd data (county type, production zone, whether animals were brought into the herd, whether animals were purchased from markets and middlemen, wildlife interaction, production type, production system, housing system, grazing system, watering system, breeding method and altitude/elevation) were entered in Microsoft Access 2010 due to the large amount of data and need to link the data tables. The required data columns from each data set were then brought together in a Microsoft Excel Spreadsheet, data cleaned and coded before being exported for descriptive analysis using IBM Statistical Package for Social Science (SPSS) Statistics for Windows Version 20 (IBM Corp., Armonk, N.Y., USA) and R version 4.0.3 (2020-10-10) for regression analysis. Descriptive analysis generated sums, means, proportions and confidence intervals. Descriptive statistics were also generated for the sero-prevalence in the two different production zones (pastoral and sedentary), for each county and for the other potential risk factors. Apparent prevalence was calculated using Eq 1 [44] while true prevalence was calculated using Eq 2 [47]. Confidence interval of the true prevalence was calculated using Eq 3 [48, 49].

Apparentprevalence=No.ofanimalstestingpositiveTotalnumberofanimalsinthegrouptestedx100 (1)
Trueprevalence=apparentprevalence+specificity-1sensitivity+specificity-1x100 (2)
(95%CIoftrueprevalence=p±1.96(pqnJ2). (3)

Where, p is apparent prevalence; q is 1-p; n is sample size and J2 is Youden’s index (Se+Sp-1) where Se is test sensitivity and Sp is test specificity.

Chi-squared test as recommended by Campbell [50] and Richardson [51] was used for pairwise comparison of proportions while the confidence intervals of the proportions were calculated using the method recommended by Altman et al. [52]. Coding in regression analyses was such that the lowest code (0), the reference, was the factor which exhibited the highest proportion/Wald statistic [53]. Test for collinearity of the variables was by testing for correlation. Simple correlation coefficients for pairs of independent variables are determined and a value of more than 0.3 was considered reasonable collinearity among a pair of independent variables and one was dropped [54]. This was done systematically until only those with correlation of 0.3 or less remained. Multivariable generalized linear mixed effects logistic regression analysis (GLMM) with county and villages as random effect variables was used to test the strength of association between the potential risk factors and FMD sero-positivity. This made use of backward fitting of variables and generated odds ratio (OR) and p values. Interaction between variables was also tested. The interpretation of odds ratios less than one were after obtaining their inverse [55]. Scaled residuals and fitted values were generated and used to evaluate the final models developed. In all the analysis, confidence level was kept at 95% and ρ≤0.05 was set for significance.

The goodness of fit test used for the regression models was the Akaike Information Criterion (AIC) which maximizes the likelihood function. The model with the lowest AIC was considered as the most parsimonious [56, 57].

Ethics

The research approval for the study was obtained from the Kenya National Commission for Science, Technology and Innovation (NACOSTI/P/19/57224/31389) and the Faculty of Veterinary Medicine Biosafety, Animal Use and Ethics Committee (FVM BAUEC/2020/262). Each owner of a herd selected for sampling provided verbal consent, once the objectives of the study were explained. Herds whose owners did not consent were replaced with the next herd in the random sample list. Other approvals required for the study were obtained from the State Department of Livestock at national level and from the respective county governments.

Results

The cross-sectional study was carried out from August to September 2016 cross-nationally. In the study, 898 herds were sampled yielding 8201 samples. The herds were more than the number calculated since, especially in the sedentary area, it was difficult to find sufficient animals in one herd. However, only 7564 samples from 872 herds were available for testing for FMD sero-prevalence as 637 were already depleted while testing for other diseases or had spilled or were grossly contaminated. Sheep samples were 2560 (33.8%) while goat samples were 5004 (66.2%). Of these 3909 (51.7%) were from the PZ and 3655 (48.3%) were from the SZ. Of the 44 counties investigated (samples from three out of 47 counties not available), 11 (25.0%) were in the PZ and 33 (75.0%) were in the SZ.

Animal and herd level descriptive statistics

S2 Table shows the number of sheep and goats in the sampled herds in the PZ and SZ. Therefore, the mean herd size in the PZ was about ten times that in the SZ. The animals in both zones were mainly females older than one year.

Table 1 presents the individual animal variable descriptive statistics in both the PZ and SZ and overall. Thus about two-thirds of the SR sampled was of caprine species. Nearly half of the animals were of local breed. About three-quarters of the SR sampled were female. Majority of the animals sampled were mature (97.0%) and born in the herds (82.9%).

Table 1. Descriptive statistics of sampled individual animal variables in the pastoral and sedentary zones, Kenya, 2016.

Variable No. in Pastoral Zone % in Pastoral Zone No. in Sedentary Zone % in Sedentary Zone Total % of Total
Species
Caprine 2694 68.9 2310 63.2 5004 66.2
Ovine 1215 31.1 1345 36.8 2560 33.8
Total 3909 100.0 3655 100.0 7564 100.0
Breed
Local 1714 43.8 1596 43.7 3310 43.8
Cross-breed 431 11.0 430 11.8 861 11.4
Exotic 178 4.6 516 14.1 694 9.2
Unidentified 1586 40.6 1113 30.5 2699 35.7
Total 3909 100.0 3655 100.0 7564 100.0
Sex
Female 3010 77.0 2912 79.7 5922 78.3
Male 894 22.9 742 20.3 1636 21.6
Unidentified 5 0.1 1 0.0 6 0.1
Total 3909 100.0 3655 100.0 7564 100.0
Age
Mature (>1 year) 3879 99.2 3456 94.6 7335 97.0
Young (≤1 year) 11 0.3 187 5.1 198 2.6
Unidentified 19 0.5 12 0.3 31 0.4
Total 3909 100.0 3655 100.0 7564 100.0
Origin
Born in herd 3145 80.5 3128 85.6 6273 82.9
Brought in 50 1.3 267 7.3 317 4.2
Unidentified 714 18.3 260 7.1 974 12.9
Total 3909 100.0 3655 100.0 7564 100.0

Table 2 presents the herd level variable descriptive statistics in both zones and overall. Although these were herd level variables, the numbers are of actual number of animals involved as most analyses in the study were at individual animal level. Overall about two-thirds of animals were in herds where SR were brought into the herds in the last one year, in herds which purchased SR from markets or middlemen, in herds under communal grazing, in herds which shared watering and in herds at altitude of less than 1500m above sea level. Just over a half of the animals were from herds which had interaction with wildlife and from herds which utilized own-male breeding method. Majority of animals were in meat and multi-purpose production type (86.1%), in the sedentary and pastoral production system (75.5%) and were enclosed at night (77.0%).

Table 2. Descriptive statistics of herd level variables in the pastoral and sedentary zones, Kenya, 2016.

Variable No. in PZ % in PZ No. in SZ % in SZ Total % of Total
Herds brought in SR?
No 2494 63.8 2273 62.2 4767 63.0
Yes 1387 35.5 1382 37.8 2769 36.6
Unidentified 28 0.7 0 0.0 28 0.4
Total 3909 100.0 3655 100.0 7564 100.0
Buy SR from market or middlemen?
No 1733 44.3 3020 82.6 4753 62.8
Yes 2176 55.7 635 17.4 2811 37.2
Total 3909 100.0 3655 100.0 7564 100.0
SR interaction with wildlife
Yes 3246 83.0 1053 28.8 4299 56.8
No 209 5.3 1242 34.0 1451 19.2
Unidentified 454 11.6 1360 37.2 1814 24.0
Total 3909 100.0 3655 100.0 7564 100.0
SR Production type
Meat 1594 40.8 1747 47.8 3341 44.2
Multipurpose 1876 48.0 1294 35.4 3170 41.9
Mixed 228 5.8 138 3.8 366 4.8
Dairy 20 0.5 170 4.7 190 2.5
Unidentified 191 4.9 306 8.4 497 6.6
Total 3909 100.0 3655 100.0 7564 100.0
SR Production System
Sedentary/mixed 265 6.8 2850 78.0 3115 41.2
Pastoral 2481 63.5 112 3.1 2593 34.3
Agro-pastoral 782 20.0 266 7.3 1048 13.9
Multiple 138 3.5 28 0.8 166 2.2
Unidentified 243 6.2 399 10.9 642 8.5
Total 3909 100.0 3655 100.0 7564 100.0
SR Housing
Enclosed at night 3061 78.3 2760 75.5 5821 77.0
None 794 20.3 592 16.2 1386 18.3
Enclosed day and night 54 1.4 303 8.3 357 4.7
Total 3909 100.0 3655 100.0 7564 100.0
SR grazing
Communal 1611 41.2 1113 30.5 2724 36.0
Fenced 318 8.1 1799 49.2 2117 28.0
Mixed 1070 27.4 198 5.4 1268 16.8
Migratory 744 19.0 42 1.1 786 10.4
Unidentified 124 3.2 234 6.4 358 4.7
Zero-grazing 42 1.1 269 7.4 311 4.1
Total 3909 100.0 3655 100.0 7564 100.0
SR watering
Shared 3529 90.3 1011 27.7 4540 60.0
On-farm 199 5.1 2226 60.9 2425 32.1
Unidentified 181 4.6 274 7.5 455 6.0
Mixed 0 0.0 144 3.9 144 1.9
Total 3909 100.0 3655 100.0 7564 100.0
SR breeding method
Own male 2059 52.7 2370 64.8 4429 58.6
Mixed 1014 25.9 230 6.3 1244 16.4
Common-use male 556 14.2 244 6.7 800 10.6
Unidentified 183 4.7 395 10.8 578 7.6
Male from another farm 64 1.6 382 10.5 446 5.9
Artificial insemination 33 0.8 34 0.9 67 0.9
Total 3909 100.0 3655 100.0 7564 100.0
SR location elevation
≤1500m 3130 80.1 1754 48.0 4884 64.6
>1500m 641 16.4 1828 50.0 2469 32.6
Unidentified 138 3.5 73 2.0 211 2.8
Total 3909 100.0 3655 100.0 7564 100.0

Sero-prevalence of FMD in small ruminants

At the time of sampling, none of the animals in the surveyed herds showed FMD clinical symptoms. Sero-prevalence of non-structural FMDV protein (antibodies) for a total of 7564 sera collected from the whole country was determined. The overall true sero-prevalence of FMD in small ruminants was 22.5% (95% CI: 22.3–24.3%). The sero-prevalence was significantly higher (p = 0.021) in the PZ at 31.2% (95% CI: 29.8–32.7%) compared to that in the SZ which had a sero-prevalence of 14.7% (95% CI: 13.4–15.7%). The sero-prevalence per county is in the S3 Table. The distribution of FMD sero-positives among SR was near ubiquitous with nearly every county registering some positives. Variations in spatial distributions of FMD sero-prevalence were observed across the country with true sero-prevalence levels higher than the national average of 22.5% recorded in 11 (25%) of counties among them Mandera, Kilifi, Lamu, Kajiado, West-Pokot, Garissa, Turkana, Wajir, Kwale Tana River and Isiolo counties, mainly in the PZ except for Kilifi, Lamu and Kwale counties. Some counties (14), mainly in the SZ namely Embu, Kisii, Nakuru, Elgeiyo- Marakwet, Kiambu, Bungoma, Kirinyaga, Vihiga and Murang’a counties had sero-prevalence of less than 10.0%. Other counties (19) in sedentary zone had sero-prevalence above 10.0% but lower than the national average. The sero-prevalence for Mombasa and Nyamira was 0.0% but the number of samples tested was too small (5 and 14 respectively) to give any meaningful interpretation.

The FMD sero-positivity per potential individual animal risk factor was as in Table 3.

Table 3. FMD Sero-positivity per potential individual animal risk factor, Kenya, 2016.

Variable Total tested Positive % Positive 95%CI of % positive χ2 p-value
Species
Caprine 5004 1202 24.0 22.9–25.2 789.68 <0.001
Ovine 2560 560 21.9 20.3–23.5
Breed
Local 3310 807 24.4 22.9–25.9 2728.79 <0.001
Cross-breed 861 207 24.0 21.2–27.1
Exotic 694 123 17.7 15.0–20.8
Unidentifiedφ 2699 25 0.9 0.6–1.4
Sex
Female 5922 1403 23.7 22.6–24.8 7406.90 <0.001
Male 1636 356 21.8 19.8–23.9
Unidentified 6 3 50.0 14.0–86.1
Age
Mature (>1 year) 7335 1731 23.6 22.6–24.6 13790.73 <0.001
Young (≤1 year) 198 20 10.1 6.4–15.4
Unidentified 31 20 35.5 19.8–54.6
Origin
Born in herd 6273 1474 23.5 22.5–24.6 8459.147 <0.001
Brought in 317 54 17.0 13.2–21.7
Unidentified 974 234 24.0 21.4–26.9

φUnidentified means that the variable was not indicated for those samples. The chi-square and p value are overall values for the differences in proportions.

For variables with more than two categories, chi-square reported in Tables 3 and 4 is for sero-prevalence for all categories. The chi-square reported in the ensuing text are for pair-wise comparison of sero-prevalence. Thus at individual animal level, the sero-positivity of FMD in caprine (goats) compared to that in ovine (sheep) was significantly higher (p<0.001). That for exotic breeds was significantly lower than that for local breeds (χ2 = 14.43; p<0.001) and cross breeds (χ2 = 9.13; p = 0.003). Sero-prevalence in mature animals was significantly higher than in young animals (p<0.001) while that in animals that were born in the herd was significantly higher than that of animals that were brought in (p<0.001).

Table 4. Sero-positivity for FMD per potential herd risk factor, Kenya, 2016.

Variable Total tested Positive % Positive 95%CI of % positive χ2 p-value
Production Zone
Pastoral (PZ) 3909 1220 31.2 29.8–32.7 5.29 0.021
Sedentary (SZ) 3655 531 14.7 13.4–15.7
Herds brought in SR?
No 4767 1160 24.3 23.1–25.6 4490.11 <0.001
Yes 2769 598 21.6 20.1–23.2
Unidentifiedφ 28 4 14.3 4.7–33.6
Buy SR from market or middlemen?
No 4753 1023 21.5 20.4–22.7 498.59 <0.001
Yes 2811 739 26.3 24.7–28.0
SR interaction with wildlife
Yes 4299 1201 27.9 26.6–29.3 1906.15 <0.001
No 1451 183 12.6 11.0–14.5
Unidentified 1814 378 20.8 19.0–22.8
SR Production type
Meat 3341 700 21.0 19.6–22.4 6732.83 <0.001
Multipurpose 3170 816 25.7 24.2–27.3
Mixed 366 70 19.1 15.3–23.6
Dairy 190 31 16.3 11.5–22.5
Unidentified 497 145 29.2 25.3–33.4
SR Production System
Sedentary/mixed 3115 463 14.9 13.6–16.2 4311.26 <0.001
Pastoral 2593 799 30.8 29.0–32.6
Agro-pastoral 1048 305 29.1 26.4–32.0
Mixed 166 37 22.3 16.4–29.5
Unidentified 642 158 24.6 21.4–28.2
SR Housing
Enclosed at night 5821 1377 23.7 22.6–24.8 6687.38 <0.001
None 1386 346 25.0 22.7–27.3
Enclosed day and night 357 39 10.9 8.0–14.7
SR grazing
Communal 2724 713 26.2 24.5–27.9 3820.75 <0.001
Fenced 2117 335 15.8 14.3–17.5
Mixed 1268 351 27.7 25.3–30.3
Migratory 786 232 29.5 26.4–32.9
Unidentified 358 96 26.8 22.4–31.8
Zero-grazing 311 35 11.3 8.1–15.4
SR watering
Shared 4540 1290 28.4 27.1–29.8 6566.08 <0.001
On-farm 2425 330 13.6 12.3–15.1
Unidentified 455 124 27.3 23.3–31.6
Mixed 144 18 12.5 7.8–19.3
SR breeding method
Own male 4429 1020 23.0 21.8–24.3 10157.63 <0.001
Mixed 1244 325 26.1 23.7–28.7
Common-use male 800 215 26.9 23.9–30.1
Unidentified 578 131 22.7 19.4–26.3
Male from another farm 446 63 14.1 11.1–17.8
Artificial insemination 67 8 11.9 5.7–22.7
SR location elevation
≤1500m 4884 1277 26.2 24.9–27.4 4332.06 <0.001
>1500m 2469 419 17.0 15.5–18.5
Unidentified 211 66 31.3 25.2–38.1

φUnidentified means that the variable was not indicated for those samples. The chi-square and p value are overall values for the differences in proportions.

The herd level prevalence, a measure of sero-prevalence in herds where at least one animal in a herd tested positive, for all the 872 herds tested was 77.6% (95% CI: 73.9–80.9), which was significantly higher than overall animal level sero-prevalence (22.5% (95% CI: 22.3–24.3). The sero-positivity per potential herd risk factor was as in Table 4.

Herds which had brought in SR in the last one year had significantly lower sero-prevalence than those that had not (p<0.001). Herds in which animals were bought from the market or middlemen had significantly higher sero-positivity than in those herds where this was not the case (p<0.001). Similarly, herds which had wildlife interaction had significantly higher sero-positivity than those without such interaction (p<0.001). The sero-positivity of herds at low altitude (≤1500m above sea level was significantly higher (p<0.001) than that of herds at higher altitude (>1500m above sea level).

Multipurpose production type herds had significantly higher sero-positivity than meat (χ2 = 20.00; p<0.001), mixed (χ2 = 7.62; p = 0.006) and dairy (χ2 = 8.41; p = 0.004) production type herds. The pastoral production system showed significantly higher sero-positivity than sedentary (χ2 = 207.61; p<0.001), agro-pastoral (χ2 = 104.96;p<0.001) and mixed (χ2 = 5.34;p = 0.021) production systems. The sero-prevalence in the sedentary production system was significantly higher than that in the mixed production system (χ2 = 6.67; p = 0.001). Herds which were not enclosed or enclosed only at night had a significantly higher sero-positivity than herds which were enclosed by day and by night (χ2 = 32.75; p<0.001 and χ2 = 31.15; p<0.001 respectively). Communal grazed herds had significantly higher sero-prevalence than fenced (χ2 = 75.94; p<0.001) and zero-grazed herds (χ2 = 33.33; p<0.001). Fenced herds had significantly higher sero-prevalence than herds with mixed grazing (χ2 = 69.50; p<0.001), herds with migratory grazing (χ2 = 68.49) and zero-grazed herds (χ2 = 4.25; p = 0.04). Herds with mixed and migratory grazing systems had significantly higher sero-prevalence than zero-grazed herds (χ2 = 36.32; p<0.001 and χ2 = 40.04; p<0.001 respectively) Small ruminant herds that had shared watering had significantly higher sero-positivity than those with on farm watering and mixed type watering (χ2 = 194.02; p<0.001; χ2 = 17.76; p<0.001 respectively). The statistically significant higher sero-prevalence with regard to breeding method were observed only between herds utilizing all other breeding methods (own male, mixed methods, common use male) and those utilizing a male from another farm (χ2 = 18.57;p<0.001, χ2 = 26.73;p<0.001, χ2 = 27.04;p<0.001 respectively) as well as those utilizing AI (χ2 = 4.61;p = 0.032), χ2 = 6.77;p = 0.009, χ2 = 7.27;p = 0.007 respectively).

Association between FMD sero-positivity and selected potential risk factors

Pairwise Spearman correlation of all the potential risk factors in Tables 3 and 4 showed significant moderate to strong correlation between many factors except age, sex, production zone, whether herds brought in SR, production type, breeding method and elevation. These were retained in the group of potential risk factors for FMD sero-positivity risk factor analysis. The most parsimonious mixed effects logistic regression model showing the association between FMD sero-positivity in small ruminants and risk factors as well as the relevant interactions are in Table 5.

Table 5. Association between FMD sero-positivity in small ruminants and risk factors studied, Kenya, 2016.

Risk factor Variable p OR 95%CI of OR
Intercept Included <0.001 2.459 2.047–2.872
Sex Female Ref
Male 0.008 0.808 0.650–0.966
Age Mature Ref
Young <0.001 0.291 -0.420–1.002
Production zone Pastoral Ref
Sedentary <0.001 0.278 -0.225–0.780
Production type Meat Ref
Multipurpose 0.042 1.307 1.049–1.566
Mixed 0.608 0.876 0.373–1.380
Dairy 0.416 1.351 0.626–2.076
Sex*age interaction Male*young 0.019 3.671 3.671–4.754
Mature Female versus young female 0.004 3.436 2.725–4.147
Mature female versus mature male 0.041 1.238 1.079–1.396
Mature female versus young male 0.986 1.158 0.322–1.995
Young female versus mature male 0.029 0.360 -0.363–1.084
Young female versus young male 0.193 0.337 -0.735–1.409
Mature male versus young male 0.999 0.936 0.090–1.782

In this final model obtained, the AIC was 7079.6 and the log likelihood was -3532.8 which indicated good fit for the data.

Only multipurpose production type showed statistically significant positive association when compared with meat production type. Thus multipurpose production type was 1.307 times more likely to be associated with FMD sero-positivity when compared with meat production type (p = 0.042). Interpretation of OR for risk factors that were negatively associated with FMD sero-positivity was after finding the inverse of OR (1/OR) as specified by Bland and Altman [55]. Therefore with reference to female animals, male animals were 1.238 times less likely to be seropositive for FMD (p = 0.008). Compared to mature animals, young animals were 3.436 times less likely to be seropositive for FMD (p = <0.001) Animals in the sedentary zone were 3.597 times less likely to be sero-positive when compared with those in the pastoral zone (p<0.001). County and village IDs (with village IDs nested within counties) were used in the model as random effects variables but both effects were non-existent. The variances and Sd associated with observations within a village and county were 1.11 (Sd = 1.05) and 0.41 (Sd = 0.67), respectively. Scaled residuals ranged between -2.30 and 5.29. A model used to investigate interactions showed that interaction between age and sex was significant (p = 0.019). An animal that was mature and female was 3.436 times more likely to be sero-positive in contrast to being young and female (p = 0.004) and 1.238 times more likely to be sero-positive in contrast to being mature and male (p = 0.041). An animal that was young and female was 2.78 (1/0.360) times less likely to be sero-positive in contrast to one that was mature and male (p = 0.029). Thus an interaction with matureness or femaleness increased the risk of FMD sero-positivity above that for sex or age alone respectively.

Discussion

The mean SR herd sizes in the PZ and SZ were 27.5 and 2.7 respectively. This is consistent with what has been reported in sub-saharan sedentary production systems [58]. The herd structure in the pastoral zone is similar to what has been reported in Somalia [59]. For the PZ, this is within the range reported recently in Kenya [38] but lower than that reported by Zaal [37], probably due to dwindling land available for livestock keeping and other changes in farming systems. According to this study, the bulk of SR in Kenya are held in the PZ.

Only 7564 samples from 872 herds were available for testing for FMD sero-prevalence compared to a calculated sample size of 9044. Though slightly lower than the calculated sample size, due to sample loss and lack of usability of some samples for the test (16%), these samples were deemed sufficient for determination of the sero-prevalence of FMD in the SR herds given that there was sufficient design effect (2) consideration and provision for sample loss in sample size calculation.

The country sero-prevalence of FMD in SR was found to be 22.5% similar to what has been reported in other countries where FMD is endemic [16, 17]. It is however higher than that reported in Ethiopia, Israel, Libya and Sudan [8, 9, 11, 12, 18] but about half of what has been reported in Tanzania and Myanmar [14, 19, 20]. A previous study in cattle in Kenya showed much higher sero-prevalence in cattle at 52.5% [60] and unpublished data obtained at the same time with this current study in Kenyan cattle revealed a sero-prevalence of 37.6%. This means sheep and goats in Kenya could be less susceptible to FMDV compared to cattle despite the fact that they are normally herded together in endemic settings of Kenya as was also observed in Ethiopia [8, 9].

In the absence of vaccination, sero-prevalence to FMDV can be an indicator of presence of FMD. Sero-prevalence was significantly higher in the PZ (31.5%) than in the SZ (14.5%). This may be attributed to a high level of herd mobility, contact of animals at grazing and watering points, dynamism of herds (frequent additions) and frequent contact with the livestock of neighbouring countries through cross-border contact in the PZ. These animals move across the boundaries for grazing, watering and also for illegal trade thus promoting the concept that FMD outbreaks are associated with animal movement. In the process of movement they also come in contact with other animals from different areas which are an important factor for the transmission of the disease. The livestock in pastoral areas also end up in some sedentary zones during the dry season, potentially spreading disease [61]. Foot and mouth being a disease spread due to movement of animals closer together makes sedentary zone have lower incidence of spread between herds. This is important because most of the SR are in the PZ where they are more often herded together with cattle and cross-transmission may be the reason for the observed sero-positivity. The sero-prevalence in counties within the PZ or bordering the PZ such as Lamu were significantly higher than those in the counties in the SZ as also reported by others [60, 62]. This might be due to differences in the movement and distribution of livestock, the level of contact between herds and ungulate wildlife, proximity to stock routes, the grazing patterns and watering sources in each county.

A significant difference was observed in sero-prevalence of FMD among mature (23.6%) and young sheep and goats (10.1%). This is in agreement with the results of others [19, 20] although the sero-positivity levels in our study were lower. The difference in sero-positivity between age groups may be due to the fact that mature animals may have experienced more exposures to FMD at grazing, watering point and at market than in age group less than one year. Therefore, adult animals might have acquired infection from multiple strains and serotypes thus producing antibodies against multiple virus incursions of FMD. It could also be due to cumulative sero-positivity through repeated infection in their longer life time. The low prevalence in young animals may also be indicative of persistent passive immunity and less frequency of exposure of the animal to the disease as the farmers keep their lambs and kids in the homesteads. Females showed higher sero-prevalence at 23.8% than males (21.9%). However, these results are in contrast to Ethiopian studies where 15.7% and 8.3% seroconversions were reported in male and female animals respectively [63] and 8.9% in female while 3.0% in male [8]. Sero-prevalence was significantly higher in the multipurpose production type than in all the other production types (meat, mixed, dairy). This may be possible because this production type is found mainly among pastoral and agro-pastoral systems where purchase of animals is from the market or middlemen and which in each case had high sero-prevalence. Other researchers have demonstrated higher FMD sero-prevalence in production types resembling the multi-purpose production type than in meat, mixed and dairy production types [11, 20] However, Mesfine et al. [8] in Ethiopia have demonstrated lower sero-prevalence in pastoral and agro-pastoral production systems than in sedentary production systems. Further, there was high sero-prevalence in animals whose production type was not identified hence the need for further investigation of sero-prevalence between the production types. The proportion of herds with at least one animal sero-positive for FMD (herd prevalence) was high at 77.6% similar to 74.7% reported by Ahmed et al [41] in Ethiopian cattle but higher than that in the reports of Megersa et al [64] in southern Ethiopian cattle and Hussain et al [65] in Omani cattle with sero-prevalence of 48.1% and 55.2%, respectively. This comparison of SR herds and cattle herds is relevant given possible transmission from cattle to SR. The high prevalence of FMD at the herd level in our study might be due to the common practice of communal grazing and watering in the study area as was also alluded to by Ahmed et al [41].

In spite of many variables showing differences in proportions of seropositive animals across the categories, only multipurpose production type showed a statistically significant positive association with FMD sero-positivity. Male sex, young age and sedentary production zone showed a statistically significant negative relationship. Thus some husbandry related variables showed significant relationship with sero-positivity as has also been alluded to by Balinda et al. [21] in Uganda. These results demand for risk-based surveillance which considers the significant risk factors. They also call for extension services and policies for small ruminant keepers to advice on interventions and husbandry practices which could limit the circulation of FMDV among SR herds which could also reduce cross-transmission with cattle herds.

Vaccination of small ruminants against FMD in Kenya is non-existent due to scarce vaccine and cost implications [34]. It may be worthwhile to vaccinate SR in some scenarios, given the identified risk factors. The possibility of transmission of FMDV from cattle to SR needs to be researched.

Limitations of the study

Testing was not done for circulating virus (e.g. virus isolation/PCR), and therefore it is unknown when these animals became sero-positive. Indeed, further investigations (potentially using the same samples) could be done and also to identify the serotypes that the SR were sero-positive to, using serotype specific ELISAs. There was significant sero-positivity in animals where some variable levels were unidentified hence the need to investigate further the level of sero-positivity with regard to these variables. Although this study was at national level, The results in some counties are useful in making conclusions about the sero-positivity of FMD in SR as there was sufficient sample size for the counties. However, in some counties the sample size was too small to make any meaningful conclusions and therefore planned studies with sufficient sample sizes are required.

Conclusion

The bulk of small ruminants in Kenya are held in the pastoral zone. Small ruminant FMD sero-positivity established in most counties countrywide shows that FMD may be present in the species in majority of herds but this needs to be authenticated through isolation of the FMD virus. The study has shown that the sero-prevalence in small ruminants in Kenya is estimated at 23.3% with sheep and goats having almost equal sero-prevalence. Given the near ubiquitous distribution of sero-prevalence, it is possible that the FMD virus may be circulating in a significant proportion of closed SR herds. There is also possible cross transmission of FMDV across the species which needs investigation. The pastoral zone had higher sero-positivity as compared to the sedentary zone. This shows the importance of concentrating control efforts in the pastoral zone where sero-positivity is high but without neglecting the sedentary areas which usually suffer the highest production and productivity losses in case of FMD outbreaks. Besides, livestock in the pastoral zone also end up in some counties in the sedentary zone during the dry season. Past efforts for control of FMD in Kenya centered on compulsory vaccination of cattle in areas mostly located in the sedentary areas. The findings of this study should be considered in the development of FMD risk-based surveillance and control plans in small ruminants alongside those of the cattle population with due consideration of the established risk factors. More risk factors should be identified through planned studies.

Supporting information

S1 Table. FMD sero-prevalence and associated risk factors in SR in various countries.

(DOCX)

S2 Table. Number of sheep and goats in the herds sampled in the study area, Kenya, 2016.

(DOCX)

S3 Table. Small ruminant FMD sero-positivity per county, Kenya, 2016.

(DOCX)

S1 File. Data collection tools.

(DOCX)

Acknowledgments

We acknowledge approval of the study by the Directorate of Veterinary Services (DVS), Kenya and respective county governments. The survey teams and Foot- and -mouth Disease Laboratory staff are acknowledged for sample and data collection as well as sample testing. The respective county livestock keepers are acknowledged for presentation of animals and provision of data. The DVS data entry team which comprised of Ruth Manasse, Peninah Khan and Nelly Achieng’ are also acknowledged. We acknowledge the assistance of M/s Jane Poole of the International Livestock Research Institute in statistical analysis of data.

Data Availability

All relevant data are within the manuscript and its S1 File, S1S3 Tables files.

Funding Statement

This study had support from a project titled “Improving Animal Disease Surveillance in Support of Trade in IGAD Member States”, in short “Surveillance of Trade Sensitive Diseases – STSD”. This was a regional component of the Supporting the Horn of Africa’s Resilience (SHARE). The project was implemented by IGAD member states through AU-IBAR and IGAD. The project was implemented with financial support from the European Union (EU). The direct recipient of the funding in Kenya was the Directorate of Veterinary Services with SWK as the National Focal Person. The ELISA Kits used in this work on FMD in small ruminants were provided by Eu-FMD through the Nakuru FMD Real -Time Training Course credit points. The direct recipient of the kits was ECC at the FMD laboratory of the Directorate of Veterinary Services. The AU-IBAR and IGAD Secretariat played a role in study design as well as training on data collection and data management in the main project. Sample testing, data analysis and publication was not funded by the main project as it fell outside the scope of the project.

References

  • 1.Falvey L. Food Security: The Contribution of Livestock. Chiang Mai Univ. J Nat Sci. 2015; 14 (1). [Google Scholar]
  • 2.Kosgey IS, Rowlands GJ, van Arendonk JAM, Baker AL. Small ruminant production in smallholder and pastoral/extensive farming systems in Kenya. Small Rumin Res. 2008; 77(1):11–24. doi: 10.1016/j.smallrumres.2008.02.005 [DOI] [Google Scholar]
  • 3.Wanyoike S. The epidemiology and socio-economics of contagious bovine pleuropneumonia and its control by vaccination in Narok District of Kenya [dissertation]. Reading (UK): University of Reading; 2009. [Google Scholar]
  • 4.Otte MJ, Chilonda P. Cattle and small ruminant production systems in sub-Saharan Africa: a systematic review. Rome: Food and Agriculture Organization of the United Nations; 2002. [Google Scholar]
  • 5.KNBS. The 2009 national population and housing census. 7th National Census. Kenya Government. Nairobi: Kenya National Bureau of Statistics; 2010.
  • 6.Mburu, JWS. Small Ruminant Production in Kenya. Proceedings of the Workshop on the Improvement of Small Ruminants in Eastern and Southern Africa; 1986 Aug 18–21; Nairobi, Kenya.
  • 7.Nyariki DM, Amwata DA. The value of pastoralism in Kenya: Application of total economic value approach. Pastoralism. 2019; 9: 9. doi: 10.1186/s13570-019-0144-x [DOI] [Google Scholar]
  • 8.Mesfine M, Nigatu S, Belayneh N, Wudu T. Jemberu WT. Sero-epidemiology of foot and mouth disease in domestic ruminants in Amhara Region, Ethiopia. Front Vet Sci. 2019; 6: 130. doi: 10.3389/fvets.2019.00130 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Abdela N. Sero-prevalence, risk factors and distribution of foot and mouth disease in Ethiopia. Acta Trop. 2017; 169: 125–132. doi: 10.1016/j.actatropica.2017.02.017 [DOI] [PubMed] [Google Scholar]
  • 10.Hegde R, Hosamani M, Sreevatsava V, Rashmi KM, Kowalli S, Nagaraja K, et al. Serosurveillance of Foot-and-Mouth Disease in Ruminant Population of Karnataka, India. SM Virol. 2016; 1(2): 1006. [Google Scholar]
  • 11.Elnekave E, van Maanen K, Shilo H1, Gelman B, Storm N, Berdenstain S, et al. (2016). Prevalence and risk factors for foot and mouth disease infection in small ruminants in Israel. Prev Vet Med. 2016; 125:82–88. doi: 10.1016/j.prevetmed.2015.12.019 [DOI] [PubMed] [Google Scholar]
  • 12.Eldaghayes I, Dayhum A, Kammon A, Sharif M, Ferrari G, Bartels C, et al. Exploiting serological data to understand the epidemiology of foot-and-mouth disease virus serotypes circulating in Libya. Open Vet J. 2017; 7(1): 1–11. doi: 10.4314/ovj.v7i1.1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Shabana I, Krimly RA. Sero-prevalence of some viral and bacterial zoonoses in domestic ruminants in Medina Iman. J Adv Vet Anim Res. 2020; 7(1): 42–50. doi: 10.5455/javar.2020.g391 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Phyoe HMM, Khaing AT, Abba Y, Aung YH, Htun LL, Htin NN, et al. Sero-prevalence of Foot and Mouth Disease Virus (FMDV) and associated risk factors in unvaccinated sheep and goats in Pyawbwe and Meikhtila townships of Myanmar. J Adv Vet Anim Res. 2017; 4(2): 161–167. doi: 10.5455/javar.2017.d204 [DOI] [Google Scholar]
  • 15.Lazarus DD, Schielen WJG, Wungak Y, Kwange D, Fasina FO. Sero-epidemiology of foot-and-mouth disease in some Border States of Nigeria. Afr J Microbiol Res. 2012; 6(8): 1756–1761. [Google Scholar]
  • 16.Ur‐Rehman S, Arshad M, Hussain I, Iqbal Z. Detection and sero-prevalence of foot and mouth disease in sheep and goats in Punjab, Pakistan. Transbound Emerg Dis. 2014. doi: 10.1111/tbed.12194 [DOI] [PubMed] [Google Scholar]
  • 17.Farooq U, Irshad H, Ullah A, Latif A, Zahur AB, Naeem K, et al. Sero-prevalence of foot-and-mouth disease in small ruminants of Pakistan. J Anim Plant Sci. 2017; 27(4): 1197–1201. [Google Scholar]
  • 18.Raouf YA, Hanan Y, Almutlab AA, Hassen AA, Ahmed Al-Majali A, Tibbo M. Role of small ruminants in the epidemiology of foot-and-mouth disease in Sudan. Bull Anim Health Prod Afr. 2017; 65 (1); 145–156. [Google Scholar]
  • 19.Torsson E, Berg M, Misinzo G, Herbe I, Kgotlele T, Päärni M, et al. Sero-prevalence and risk factors for peste des petits ruminants and selected differential diagnosis in sheep and goats in Tanzania. J Infect Ecol Epidemiol. 2017; 7:1. doi: 10.1080/20008686.2017.1368336 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Casey-Bryars M. The epidemiology of foot-and-mouth disease at the wildlife-livestock interface in northern Tanzania [Dissertation]. Scotland: University of Glasgow; 2016 [Google Scholar]
  • 21.Balinda SN, Tjørnehøj K, Muwanika VB, Sangula AK, Mwiine FN, Ayebazibwe C, et al. Prevalence estimates of antibodies towards foot-and-mouth disease virus in small ruminants in Uganda. Transbound Emerg Dis. 2009; 56 (9–10): 362–371. doi: 10.1111/j.1865-1682.2009.01094.x [DOI] [PubMed] [Google Scholar]
  • 22.Arzt J, Baxt B, Grubman MJ, Jackson T, Juleff N, Rhyan J, et al. The pathogenesis of foot-and-mouth disease ii: viral pathways in swine, small ruminants, and wildlife; myotropism, chronic syndromes, and molecular virus-host interactions. Transbound Emerg Dis. 2011; 58(4):305–326. doi: 10.1111/j.1865-1682.2011.01236.x [DOI] [PubMed] [Google Scholar]
  • 23.OIE. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals 8th Edition. 2018. https://www.oie.int/standard-setting/terrestrial-manual/
  • 24.Mason PW, Grubman MJ, Baxt B. Molecular basis of pathogenesis of FMDV. Virus Res. 2003; 91: 9–32. doi: 10.1016/s0168-1702(02)00257-5 [DOI] [PubMed] [Google Scholar]
  • 25.Mahmoud MAE, Ghazy AA, Shaapan RM. Diagnosis and control of foot and mouth disease (FMD) in dairy small ruminants; sheep and goats. Int J Dairy Sci. 2019; 14: 45–52. doi: 10.3923/ijds.2019.45.52 [DOI] [Google Scholar]
  • 26.Radostits OM, Gay CC, Hinchcliff KW, Constable PD. Veterinary medicine: A textbook of the diseases of cattle, horses, sheep, pigs and goats. 10th ed. Philadelphia: W.B. Saunders; 2007. [Google Scholar]
  • 27.Stenfeldt C, Pacheco JM, Rodriguez LL, Arzt J. Early events in the pathogenesis of foot-and-mouth disease in pigs; identification of oropharyngeal tonsils as sites of primary and sustained viral replication. PLoS ONE. 2014; doi: 10.1371/journal.pone.0106859 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Barnett PV, Cox SJ. The role of small ruminants in the epidemiology and transmission of foot-and-mouth disease. Vet J. 1999; 158: 6–13. doi: 10.1053/tvjl.1998.0338 [DOI] [PubMed] [Google Scholar]
  • 29.Donaldson AI, Sellers RF, Martin WB, Aitken ID, editors. Foot-and-mouth disease. Diseases of sheep. Oxford: Blackwell Science; 2000. p. 254–258. [Google Scholar]
  • 30.Kitching RP, Hughes GJ. Clinical variation in foot and mouth disease: sheep and goats. Rev Sci Tech. 2002; 21:505–512. doi: 10.20506/rst.21.3.1342 [DOI] [PubMed] [Google Scholar]
  • 31.Parida S, Fleming L, Gibson D, Hamblin PA, Grazioli S, Emiliana Brocchi E et al. Bovine Serum Panel for Evaluating Foot-and-Mouth Disease Virus Nonstructural Protein Antibody Tests. J Vet Diagn. 2007; 19(5): 539–544. doi: 10.1177/104063870701900513 [DOI] [PubMed] [Google Scholar]
  • 32.Parida S. Vaccination against foot-and-mouth disease virus: Strategies and effectiveness. Expert Rev Vaccines. 2009; 8:347–365. doi: 10.1586/14760584.8.3.347 [DOI] [PubMed] [Google Scholar]
  • 33.Wekesa SN, Muwanika VB, Siegmund HR, Sangula AK, Namatovu A, Dhikusooka M, et al. Analysis of recent serotype O foot and mouth disease viruses from livestock in Kenya; evidence of four independently evolving lineages. Transbound Emerg Dis. 2015; 62(3): 305–314. doi: 10.1111/tbed.12152 [DOI] [PubMed] [Google Scholar]
  • 34.Nyaguthii DM, Armson B, Kitala PM, Sanz-Bernardo B, Di Nardo A, Lyons NA. Knowledge and risk factors for foot-and-mouth disease among small-scale dairy farmers in an endemic setting. Vet Res. 2019; 50: 33. doi: 10.1186/s13567-019-0652-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Sombroek WG, Braun, HMH, van der Pouw BJA. Exploratory Soil Map and Agro-Climatic Zone Map of Kenya, 1980. Scale: 1:1’000’000. Exploratory Soil Survey Report No. E1. 1982. Kenya Soil Survey Ministry of Agriculture—National Agricultural Laboratories, Nairobi, Kenya.
  • 36.Onono JO, Wieland B, Rushton J. Constraints to cattle production in semi-arid pastoral system in Kenya. Trop Anim Health Prod. 2013; 45:1415–1422. doi: 10.1007/s11250-013-0379-2 [DOI] [PubMed] [Google Scholar]
  • 37.Zaal F. Pastoralism in a global age: livestock marketing and pastoral commercial activities in Kenya and Burkina Faso [dissertation]. The Netherlands: University of Amsterdam; 1998. [Google Scholar]
  • 38.Mwanyumba PM, Wahome RW, MacOpiyo L, Kanyari P. Livestock herd structures and dynamics in Garissa county, Kenya. Pastoralism. 2015; 5: 26. doi: 10.1186/s13570-015-0045-6 [DOI] [Google Scholar]
  • 39.Jahnke HE. Livestock production systems and livestock development in tropical Africa. Kiel, Germany, Wissenschaftsverlag Vauk; 1982. [Google Scholar]
  • 40.Humpry RW, Cameron A, Gunn GJ. A practical approach to calculate sample size for herd prevalence surveys. Prev Vet Med. 2004; 65: 173–188. doi: 10.1016/j.prevetmed.2004.07.003 [DOI] [PubMed] [Google Scholar]
  • 41.Ahmed B, Megersa L, Mulatu G, Siraj M, Boneya G. Sero-prevalence and associated risk factors of foot and mouth disease in cattle in West Shewa zone, Ethiopia. Vet Med Int. 2020; doi: 10.1155/2020/6821809 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Otte MJ, Gumm ID. Intra-cluster correlation coefficients of 20 infections calculated from the results of cluster-sample surveys. Prev Vet Med. 1997; 3 (1): 147–150. doi: 10.1016/s0167-5877(96)01108-7 [DOI] [PubMed] [Google Scholar]
  • 43.Rowe AK, Lama M, Onikpo F, Deming MS. "Design effects and intraclass correlation coefficients from a health facility cluster survey in Benin". Int J Qual Health Care. 2002; 14 (6): 521–523. doi: 10.1093/intqhc/14.6.521 [DOI] [PubMed] [Google Scholar]
  • 44.Thrusfield M, Veterinary Epidemiology. 3rd ed. Oxford, UK. Blackwell Publishing; 2007. doi: 10.1038/nature05604 [DOI] [Google Scholar]
  • 45.Niewiesk S. Maternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies. Front Immunol. 2014; 5: 446. doi: 10.3389/fimmu.2014.00446 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Eubanks DL. Dental Considerations in Cows and Goats. J Vet Dent. 2012; 29(3): 200–203. doi: 10.1177/089875641202900314 [DOI] [PubMed] [Google Scholar]
  • 47.Rogan WJ, Gladen B. Estimating prevalence from the results of a screening test. Am J of Epidemiol. 1978; 107:71–76. doi: 10.1093/oxfordjournals.aje.a112510 [DOI] [PubMed] [Google Scholar]
  • 48.Greiner M. & Gardner I.A. Application of diagnostic tests in veterinary epidemiologic studies. Prev Vet Med. 2000; 45 (1–2): 43–59. doi: 10.1016/s0167-5877(00)00116-1 [DOI] [PubMed] [Google Scholar]
  • 49.Reiczigel J, Földi J, Ozsvári L. Exact confidence limits for prevalence of a disease with an imperfect diagnostic test, Epidemiol Infect. 2010; 138:1674–1678. doi: 10.1017/S0950268810000385 [DOI] [PubMed] [Google Scholar]
  • 50.Richardson JTE. The analysis of 2 x 2 contingency tables—Yet again. Stat Med. 2011; 30:890. doi: 10.1002/sim.4116 [DOI] [PubMed] [Google Scholar]
  • 51.Altman DG, Machin D, Bryant TN, Gardner MJ, editors. Statistics with confidence: confidence intervals and statistical guidelines, 2nd ed. BMJ Books; 2000. [Google Scholar]
  • 52.Guo-Wen S, Shook TL, Kay GL. (1996). Inappropriate use of bivariable analysis to screen risk factors for use in multivariable analysis. J Clin Epidemiol. 1996; 49 (8): 907–916. doi: 10.1016/0895-4356(96)00025-x [DOI] [PubMed] [Google Scholar]
  • 53.Grace-Martin K. Strategies for choosing the reference category in dummy coding https://www.theanalysisfactor.com/strategies-dummy-coding/
  • 54.Kennedy P. (1985): A Guide to Econometrics. 2nd ed. Cambridge: Basil Blackwell; 1985. [Google Scholar]
  • 55.Bland JM, Altman DG. The odds ratio. BMJ. 2000; 320 (7247): 1468. doi: 10.1136/bmj.320.7247.1468 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Burnham KP, Anderson DR. Multimodel inference: understanding AIC and BIC in Model Selection. Sociol Methods Res. 2004; 33: 261–304. doi: 10.1177/0049124104268644 [DOI] [Google Scholar]
  • 57.Cavanaugh JE, Neath AA. The Akaike information criterion. WIREs Comp Stats. 2019; 11 (3): e1460, doi: 10.1002/wics.1460 [DOI] [Google Scholar]
  • 58.Chilonda P, Van Huylenbroeck G, D’Haese L, Musaba EC, Samui KL, Ahmadu B. Small-scale cattle production in Eastern Province, Zambia: objectives, productivity and constraints. Outlook Agric. 2000; 29 (2): 109–121. [Google Scholar]
  • 59.Abdullahi AM. Pastoral production systems in Africa: a study of nomadic household economy and livestock marketing in Central Somalia. Farming systems and resource economics in the tropics. Vol. 8. Kiel, Germany, Wissenschaftsverlag Vauk; 1990. [Google Scholar]
  • 60.Kibore B, Gitao CG, Sangula A, Kitala P. Foot-and-mouth disease sero-prevalence in cattle in Kenya. J Vet Med Anim Health. 2013; 5(9): 262–268. [Google Scholar]
  • 61.Wanyoike SW. Assessment and mapping of contagious bovine pleuropneumonia in Kenya: past and present [Dissertation]. Berlin and Addis Ababa. Freie Universitat Berlin and Addis Ababa University; 1999. [Google Scholar]
  • 62.Chepkwony EC, Gitao GC, Muchemi GM. Sero-prevalence of Foot and Mouth Disease in the Somali Eco-System in Kenya. Int J Anim Vet Adv. 2012; 4(3): 198–203. [Google Scholar]
  • 63.Jenbere S, Etana M, Negussie H. Study on the risk factors of foot and mouth disease in selected districts of Afar Pastoral Area, northeast Ethiopia. J AnimVet Adv. 2011; 10(11): 1368–1372. [Google Scholar]
  • 64.Megersa B, Beyene B, Abunna F, Regassa A, Amenu K, Rufael T. Risk factors for foot and mouth disease sero-prevalence in indigenous cattle in Southern Ethiopia: the effect of production system. Trop Anim Health Prod. 2009; 41(6): 891–898. doi: 10.1007/s11250-008-9276-5 [DOI] [PubMed] [Google Scholar]
  • 65.Hussain MH, Body MHH, Al-Subhi AHA, Al-Senaidi NYA, Eltahir HA, Mansoor MK, et al. Sero-epidemiology of foot and mouth disease (FMD) virus non-structural protein (NSP) antibodies in the livestock of Oman. Acta Trop. 2019;199: p. 105106. doi: 10.1016/j.actatropica.2019.105106 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Jagadeesh Bayry

6 Aug 2020

PONE-D-20-15166

Epidemiological study on foot-and-mouth disease in small ruminants: sero-prevalence and risk factor assessment in Kenya

PLOS ONE

Dear Dr. Kairu-Wanyoike,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Details on the sampling procedure, sample size and descriptive analysis the number of animals that were vaccinated for FMD and those with clinical signs are lacking. Several parts of introduction, results and discussion are repeated throughout the text.

Please submit your revised manuscript by Sep 20 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Jagadeesh Bayry, DVM, PhD, HDR

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. In your Methods section, please provide additional location information of the study sites, including geographic coordinates for the data set if available.

3. We note that Figure1, 2, 3 in your submission containmap images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.

We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:

3.1.    You may seek permission from the original copyright holder of Figure1, 2, 3 to publish the content specifically under the CC BY 4.0 license.

We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text:

“I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.”

Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission.

In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].”

3.2.    If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.

The following resources for replacing copyrighted map figures may be helpful:

USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/

The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/

Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.html

NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/

Landsat: http://landsat.visibleearth.nasa.gov/

USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/#

Natural Earth (public domain): http://www.naturalearthdata.com/

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Comments of the authors

General comments

The study on ‘Epidemiological study on foot-and-mouth disease in small ruminants: sero-prevalence and risk factor assessment in Kenya’ is a good and useful study that documented the prevalence of the disease at national level and identified risk factors of the disease that can assist risk based surveillance and control intervention in Kenya. The study has collected quite large and fairly representative sample of the country’s small ruminant population that could generate reliable results. However the manuscript needs improvement in several ways and the following comments are forwarded to improve the manuscript

The introduction is very long. Eight page introduction for research article is unusual.

There is lack of clarity in in the sampling procedure and sample size determination. The sampling procedure is not clear. Specially the term ‘herd’ was defined in different ways and used inconsistently. This made difficult to understand how the multistage sampling method was used. It was not also clear why the sample size was determined independently for the two zones (PZ and SZ). The same inputs (parameters) were used in each zone and the same number of herds and animals were taken from each zone. If the interest was to stratify the sample, the nationally determined sample size could have been divided among the zones.

The risk factor analysis was done using chi-square, and bivariable (I would suggest to name this univariable) and multivariable logistic regressions. If univariable logistic regression is done, the chi-square analysis is redundant and anything about chi-square in the manuscript should be removed. Looking in to that analysis even the univariable logistic regression is not important as it has not been used for screening the potential risk factor for the multivariable analysis. For that matter, given the adequate sample size, screening the variables is not needed and the univariable analysis can be ignored. Another problem with the analysis was; while the sampling procedure is cluster sampling, the analysis did not consider the sampling procedure. If cluster sampling is used there will underestimation of standard error (unwarranted significant p-values for regression coefficients) and this has to be taken care of. I would suggest use of mixed effect logistic regression with ‘herds’ and ‘villages’ as random effect variables for more reliable identification of factors associated with the disease.

The result has unnecessary detail and redundant results. In line with the comments given in statistical analysis above, the chi-square test and the univariable analysis provides the same result and there is no any need to do the chi-square analysis. The univaraible logistic regression give more information like crude odds ratio for each category of the categorical variables which is not directly possible in the chi-square analysis. So I suggest anything related the chi-square analysis. Even the importance of the univariable analysis result should be re-considred.

The discussion of the risk factor should be based on the significance of risk factors in the final multivariable model not on crude association seen from the univariable analysis.

All the conclusions should be supported by the study findings which was not the case for some the recommendations

The manuscript also needs improvement in the English.

Specific Comments

Abstract

The abstract followed unstructured format. In this type format the abstract should be written in one paragraph.

Line 33-32. No need of mentioning the statistical software in the abstract.

Line 34-5. If logistic regression is done, the use chi-square for risk factor analysis will be redundancy

Line 39 – 4 . Re -write it as “ the risk factors that were significantly positively associated with FMD sero-positivity in SR were being multipurpose (OR=1.150; p=0.034) and dairy (OR=2.029; p=0.003) production types.”

Line 51…’carrier SR’…... Subclinical carrier? You didn’t have any result that showed SR are acting as carriers FMD.

Introduction

- The introduction is very long it has to be shortened to maximum of not more than 2-3 pages. E.g. the extensive discussion about differential diagnosis and the different diagnostic assays can be removed. The extensive description of the small ruminant production system in Kenya can be shorted and taken to material and methods part. The extensive discussion about the seroprevalence of SR FMD and production systems worldwide can be shortened or removed.

Line 154. They ARE……

Line 166. Average HERD SIZE of sheep and goats

Line 176. .

Line 183. Is FMD important in sheep and goat as cause of production loss or for its epidemiological contributions for cattle? Just compare this with next paragraph (line 186-19)

Lin 2011-15. Do these studies support your claim that trade costs are more important than direct cost of FMD for households? Do these SM keeper households participate international trade to countries that free of the disease?

Line 226-230. The two sentences seem contradictory

Materials and methods

Line 248-9. ……………...since FMD is a transboundary disease and also transmitted through export of animals and animal products.

Line 255-57. ‘The study targeted the sub location’ this is not clear. In epidemiology target population has its own technical meaning. The target population in this study is the national SR population. Rephrase this sentence to write what you mean.

Line 252-7. Although the section title is study area, the text in this paragraph is more about study population

Line 283. Sample size calculation was in two stages and per zone) IN EACH STRATUM:

Line 286. Make clear what is in-contact farm

Line 287 …………… “assuming a simple random sample of herds in each stratum independently” not clear

Line 294 …………’simple random sample” SIMPLE RANDOM SAMPLING? But two line down it describes a cluster sampling in which first sub-locations are selected then household herds and then animals?

Line 297. ‘323 sub-locations’. The 323 were herds which were defined as farms/in contact farms not sub-location! Again on next line it says “one village (herd)” and ‘”household herd per village”. Please make clear what herd is and use it consistently; not “herd” one time and “household herd’ another time unless they are meant different things.

If the interest is to do stratified sampling the approach could have been determining the sample size using one of the sampling techniques (looks cluster sampling in this study case) and allocating the sample among the strata proportionally or if there reason not to allocate proportionally use other method of allocation. I couldn’t see the need to determine the sample size for the two strata independently as all the parameter used are the same for each stratum.

Line 243. What are field freezers?

Line 343 -344 . ‘One aliquot was used to test for the presence or absence of antibodies of Rift Valley Fever (RVF) and Peste de Petits Ruminants (PPR) antibodies according to the objective of the STSD project’ Give some explanation about this work and make clear that the present FMD work is a part or accompany of that work.

Line 363-63. Rewrite the sentence avoiding repetitions and put the right reference for the test kit (product, Manufacture Company and place/country).

Line 365-67 On the seropositivity/negativity to FMDV antibodies the outcome variables were categorised based on the on the results of the 3ABC blocking enzyme-linked immunosorbent assay.

Line 367-73. The test procedure is not clearly documented. Revise the English.

Line 390-94. Why was the herd level variables first entered to MS access (unlike the animal level variables which are directly entered to MS excel) before being brought to MS excel for data cleaning and coding?

Line 402- To do this you need to document the se and sp of the test in the laboratory diagnosis section.

Line 403- 433 statistical analysis part has lot of repetition and unnecessary detail. For example lin4 405-6 has the same idea with line 402-405 both of them are about crude association using chi-square. But few lines down it mention bivariable analysis is done. The chi- square test of comparison and bivariable analysis are the same and the chi-square is not needed for variables in considered in the bivariable logistic regressions

The terminology bivariable is not correct has to be changed into univariable. The common usage is univariable and multivariable. It about the number of independent variables. If only one independent variable is included it is univariable and if more than one indnepenet variables is included it is multivariable.

Line 434-36 The results of our study have been presented mainly in tables and figures and interpreted in text. Although the bivariable regression was carried out for all risk factors (individual animal and herd level) together, the results are in two tables to avoid too large a table.

Other issues in this section;

- The purpose the univariable analysis should be mentioned.

- For goodness of it test, it is enough to mention what tests are used with appropriate reference. How each test measures goodness of fit is unnecessary detail.

- In several places in this part the word’ interpretation’ is incorrectly used. For example specifying confidence interval level and P- values (419-20) or putting results in text (line 434-35) are not interpretations. Interpretations ae given meaning for you findings that is done in the discussion.

Results

Line 450. In M&M, the number of herds sampled was stated as 323 herds* 2 strata = 646 so how the herd number increased to 898.

Line 451. Mention why the remaining samples were not available for testing

Line 472. However a large proportion ……

Line 482. Write in the full ideas instead of using “so” to make it clearer

Line 496. What is the diffidence between communal grazing and mixed grazing

Line 515-16. Sero-prevalence of a total of 7564 sera from the whole country was determined for the

presence of non-structural FMDV protein (antibodies).

Line 517. “Prevalence rate” Prevalence is not rate. Simply use prevalence (which known to be proportion). Correct this throughout the document.

Line 518. if χ2 has to be reported it has to include the degrees of freedom like χ2(3), which means χ2 at 3 degrees of freedom. Do this throughout the manuscript

Line 516. Write it as apparent prevalence as you have also true prevalence estimate

Line 527. ‘Showed seronegativity’ is not good expression; state that prevalence in these counties is zero

Line 530. Put the estimated true Seroprevalence in figure.

Line 531-535. What does samplings sites represent, villages, individual herds or what? the map in figure 3 does not provide any information except the distribution of sampling sites. It should have indicate the negative sites as well. Moreover the legend and labels in the maps are not visible.

Line 539 PAIR WISE Pearson correlation…………

Line 539 …‘between county and production zone”….. No risk factor variable called ‘county type’ was mentioned in the list of variables indicated M&M part. Moreover test of collinearity is needed for the multivariable analysis. So this sentence should go down where multivariable results are documented. Another issue here is the use of the term ‘risk factor” should be replaced by “potential risk factor”. The variables are hypothesized to be a risk factor, not yet confirmed to be risk factor. They will be risk factor when they are found so after the analysis. So they should be referred to as potential risk factors thought out the document until they are confirmed.

Line 546-47. Where is the result of the statistical analysis i.e. P-value

Line 546-53. In this section it seems χ2 is used but in chi-square for comparison of three or more groups, it tells you only whether there is significant difference in the proportion/ prevalence among all groups. It doesn’t tell you between which pairs is the difference significant. So how can you come up with this results where the variables has three categories like breed (exotic, local, cross)?

Line 554. Replace ‘the between herd prevalence’ with ‘herd level prevalence”

Line 564. If it is not significant, why is it surprising? In the first place, in the result section just put what you find; such interpretation should be reserved for the discussion

Line 566-71. The same comment as above in line 546-53.

Line 604- 5. The result emphasis should be which factors are significantly associated with FMD seropositivty. Whether the association is positive or negative depends how the data was coded during analysis. For example, it is not sex that is negatively associated but it is being maleness.

Line 604. Instead of table 5, S4 and S5 should be part of the main manuscript not supplementary.

Line 612. S5 table attached is not about the herd level variables. Check whether the attached table is the right one.

Line 612-13. The comparator should be mentioned.

Line 627-8. The purpose of univaraible analysis is to screen the potential risk factors. If cut off p-value 0.2 does not reduce them small cut off should have been used. Actually given the very large sample size there was no need to screen in this study and univaraible analysis was not necessary.

Line 645-76. Repetition of the table. Enough to mention the most salient results and leave the remaining detail to be referred from table

Discussion

Line 685. Delete ‘It is true’ and start with ‘According to this study …..’

Line 724-30. For SR age of 6 months and above can be considered as matured as they can be bred at this age and classification of mature above 1years of age is not appropriate. Hence it difficult to think these age animals (age 6 months – 1 year) will be kept at homestead and are less exposed to the disease. The observed higher prevalence in older animals could also be due cumulative seropositivity through repeated infection in their longer life time.

Line 730. conversely

Line 731. ‘Female posted’ change the word ‘posted’ with other more appropriate word

Line 730-32. Both the univariable and the multivariable analysis showed females have significantly higher prevalence than males. Which result is being discussed here!

Line 740 ‘….position…’ to mean explanation?

Line 745. Change the word ‘contrary’ with the actual type purchase it self

Line 749-50. not clear

Line 755-59. Make it clearer

Line 768. … three..

Line 784-95. Merge this discussion with preceding paragraphs. In the first place, what should be discussed is the result of the final model where confounding is controlled. It is meaningless to discuss the crude results of the chi-square or univariable analysis as these can’t correctly identify significant risk factors because of confounding. So the discussion in the preceding paragraphs should be adjusted accordingly.

Conclusion

Line 820-21. “The findings of this study give an understanding of the potential role of small ruminants in the epidemiology of FMD in Kenya and contribute to the global scenario’ Not exactly. It is difficult to say anything about the role of SR in epidemiology of FMD based on this study.

Line 824-25. You found high Seroprevalence does not confirm that they transmit and maintain the disease. So this conclusion cannot be warranted based on your findings.

Line 826. “Cross contamination” has to be replaced with cross transmission

Line 827. ‘This outlays’?

Line 829 ..”post”.. ??

Figures

The legends and labels of all figures (fig.1,2,3) are not visible

Reviewer #2: This study aims to determine the seroprevalence of FMD in small ruminants and determine the risk factors associated. This is an original, highly useful study that may be utilised to further understand the epidemiology of FMD transmission in Kenya.

The manuscript is very thorough, however is much too long, particularly the introduction. The whole manuscript needs to be made more concise, as there is a lot of repetition throughout, between sections, between the text and figures, and between figures. Some tables could be merged, with some columns removed – for example tables 3 and S4. The current layout makes it more confusing to the reader than it needs to be – as this is a simple study approach with good results. However, the message seems to get lost in the length of the manuscript.

For the introduction, only information relevant to the study should be included, for example detail on molecular tests and differential diagnosis is not required – potentially only mentioned. Much of the information is or could be included in the discussion if it is necessary. Additionally, please ensure that you include references where appropriate, there are multiple sections where there are not enough references.

The methods section is very repetitive, particularly regarding the description of the number of counties, and the data analysis section could be much more concise. Additionally, the ELISA method does not need to be described in such detail as it is a commonly used test.

In the results section, please ensure that your subheadings accurately reflect what is included within them and avoid repetition between tables and the text. Additionally, are chi-squared test required if regression has been done? Or can this be more concisely displayed e.g. all in one table? At the moment it is very difficult to flip between all of the tables and the lengthy text to work out the results.

Additionally, I would like to see in the descriptive analysis the number of animals that were vaccinated for FMD and that had clinical signs (even if it was 0). This is very important information when investigating seroprevalence. Particularly when the vaccines administered in Kenya are often not of high quality and may induce NSP antibodies – this should also be mentioned in the discussion.

Additionally, please be careful with capitalised words that do not need to be, for example ‘county’ and directions (east/west etc.)

Consequently I recommend major revisions to this manuscript to make it more 'reader friendly'.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Bryony Armson

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Aug 2;16(8):e0234286. doi: 10.1371/journal.pone.0234286.r002

Author response to Decision Letter 0


24 Feb 2021

Salome Kairu-Wanyoike,

Meat Training Institute,

Directorate of Veterinary Services,

State Department of Livestock,

P.O. Box 55-00204,

Athi-River, Kenya.

February 5 2021

The Editor

PLoS ONE Journal

Dear Editor,

I write to submit the corrected manuscript “Epidemiological study on foot-and-mouth disease in small ruminants: sero-prevalence and risk factor assessment in Kenya” as a full research article to PLoS ONE.

All the authors reviewed this corrected manuscript and agree to the submission. There are no opposed reviewers. We very much appreciate the opportunity that has been offered to us to correct the manuscript and the valuable inputs by the reviewers. Appended is the response to reviewers on issues raised.

Sincerely,

Salome Kairu-Wanyoike, Ph.D.

2. In your Methods section, please provide additional location information of the study sites, including geographic coordinates for the data set if available.

Provided in an updated file now S2 file

3. We note that Figure1, 2, 3 in your submission containmap images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.

Figures 2 and 3 were produced as part of the project work by part of the authors of this manuscript who were the principal investigators in the project. The figures may however be in project reports and documents which may appear online elsewhere. Figures 1 and 3 have been removed. Figure 2 has been retained to give a pictorial overview of the study zones and sampling sites.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

This has been addressed.

Reviewer #2: Yes

________________________________________

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

This has been addressed.

Reviewer #2: Yes

________________________________________

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

________________________________________

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

________________________________________

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Comments of the authors

General comments

The study on ‘Epidemiological study on foot-and-mouth disease in small ruminants: sero-prevalence and risk factor assessment in Kenya’ is a good and useful study that documented the prevalence of the disease at national level and identified risk factors of the disease that can assist risk based surveillance and control intervention in Kenya. The study has collected quite large and fairly representative sample of the country’s small ruminant population that could generate reliable results.

Compliments appreciated

However the manuscript needs improvement in several ways and the following comments are forwarded to improve the manuscript

The introduction is very long. Eight page introduction for research article is unusual.

The introduction has been reduced considerably.

There is lack of clarity in in the sampling procedure and sample size determination. The sampling procedure is not clear. Specially the term ‘herd’ was defined in different ways and used inconsistently. This made difficult to understand how the multistage sampling method was used. It was not also clear why the sample size was determined independently for the two zones (PZ and SZ). The same inputs (parameters) were used in each zone and the same number of herds and animals were taken from each zone. If the interest was to stratify the sample, the nationally determined sample size could have been divided among the zones.

These have been clarified in the various sections.

The risk factor analysis was done using chi-square, and bivariable (I would suggest to name this univariable) and multivariable logistic regressions. If univariable logistic regression is done, the chi-square analysis is redundant and anything about chi-square in the manuscript should be removed. Looking in to that analysis even the univariable logistic regression is not important as it has not been used for screening the potential risk factor for the multivariable analysis. For that matter, given the adequate sample size, screening the variables is not needed and the univariable analysis can be ignored.

Chi-square analysis and univariable regression analysis for test of association have been removed. The only Chi-square analyses remaining in the manuscript are for the test of difference in proportions.

Another problem with the analysis was; while the sampling procedure is cluster sampling, the analysis did not consider the sampling procedure. If cluster sampling is used there will underestimation of standard error (unwarranted significant p-values for regression coefficients) and this has to be taken care of. I would suggest use of mixed effect logistic regression with ‘herds’ and ‘villages’ as random effect variables for more reliable identification of factors associated with the disease.

Generalized linear mixed effects logistic regression models have been run with county and villages as random effect variables. Interactions between fixed effect variables has also been tested.

The result has unnecessary detail and redundant results. In line with the comments given in statistical analysis above, the chi-square test and the univariable analysis provides the same result and there is no any need to do the chi-square analysis. The univaraible logistic regression give more information like crude odds ratio for each category of the categorical variables which is not directly possible in the chi-square analysis. So I suggest anything related the chi-square analysis. Even the importance of the univariable analysis result should be re-considered.

Removed as stated above.

The discussion of the risk factor should be based on the significance of risk factors in the final multivariable model not on crude association seen from the univariable analysis.

Chi-square and univariable analyses have been removed

All the conclusions should be supported by the study findings which was not the case for some the recommendations

This has been done

The manuscript also needs improvement in the English.

English has been corrected throughout the manuscript

Specific Comments

Abstract

The abstract followed unstructured format. In this type format the abstract should be written in one paragraph.

The abstract is now in one paragraph

Line 33-32. No need of mentioning the statistical software in the abstract.

Statistical software has been removed on Line 33/34

Line 34-5. If logistic regression is done, the use chi-square for risk factor analysis will be redundancy

Chi-square has been removed in Line 36

Line 39 – 40 . Re -write it as “ the risk factors that were significantly positively associated with FMD sero-positivity in SR were being multipurpose (OR=1.150; p=0.034) and dairy (OR=2.029; p=0.003) production types.”

Done in Line 39-41

Line 51…’carrier SR’…... Subclinical carrier? You didn’t have any result that showed SR are acting as carriers FMD.

The term ‘carrier’ has been removed on Line 57

Introduction

The introduction is very long it has to be shortened to maximum of not more than 2-3 pages. E.g. the extensive discussion about differential diagnosis and the different diagnostic assays can be removed. The extensive description of the small ruminant production system in Kenya can be shorted and taken to material and methods part. The extensive discussion about the seroprevalence of SR FMD and production systems worldwide can be shortened or removed.

The introduction has been shortened.

Line 154. They ARE……

Corrected on Line 67.

Line 166. Average HERD SIZE of sheep and goats

Corrected on Line 385 in materials and methods.

Line 176. .

Line 183. Is FMD important in sheep and goat as cause of production loss or for its epidemiological contributions for cattle? Just compare this with next paragraph (line 186-19)

Sentence has been removed.

Lin 2011-15. Do these studies support your claim that trade costs are more important than direct cost of FMD for households? Do these SM keeper households participate international trade to countries that free of the disease?

Sentence has been removed

Line 226-230. The two sentences seem contradictory

The two sentences have been removed.

Materials and methods

Line 248-9. ……………...since FMD is a transboundary disease and also transmitted through export of animals and animal products.

Corrected on Line 145-147

Line 255-57. ‘The study targeted the sub location’ this is not clear. In epidemiology target population has its own technical meaning. The target population in this study is the national SR population. Rephrase this sentence to write what you mean.

Rephrased on Line 341-342

Line 252-7. Although the section title is study area, the text in this paragraph is more about study population

A study population section has been created

Line 283. Sample size calculation was in two stages and per zone) IN EACH STRATUM:

Included in Line 394

Line 286. Make clear what is in-contact farm

Clarified on Line 397-398

Line 287 …………… “assuming a simple random sample of herds in each stratum independently” not clear

The phrase has been deleted in Line 398-399

Line 294 …………’simple random sample” SIMPLE RANDOM SAMPLING? But two line down it describes a cluster sampling in which first sub-locations are selected then household herds and then animals?

Phrase has been removed in Line 405-406.

Line 297. ‘323 sub-locations’. The 323 were herds which were defined as farms/in contact farms not sub-location! Again on next line it says “one village (herd)” and ‘”household herd per village”. Please make clear what herd is and use it consistently; not “herd” one time and “household herd’ another time unless they are meant different things.

Clarified on Line 408-413. But note that because it was one village per sub-location and one herd per village, it is appropriate to use the terms interchangeably but one term has now been maintained for consistency.

If the interest is to do stratified sampling the approach could have been determining the sample size using one of the sampling techniques (looks cluster sampling in this study case) and allocating the sample among the strata proportionally or if there reason not to allocate proportionally use other method of allocation. I couldn’t see the need to determine the sample size for the two strata independently as all the parameter used are the same for each stratum.

The cluster sampling was more appropriate given the administrative structure of the country. The two zones are quite distinct in structure even if FMD dynamics (in cattle) seem not very different. The SZ has small counties with very many sub-locations while the PZ has large counties with fewer sub-locations which could have led to high sampling in the SZ and low sampling in the PZ. It was also important to see the difference in the two zones and we chose to have a complete separation between the two and sample equal number of sub-locations in each. This is also explained in line 414-421.

Line 243. What are field freezers?

Clarified on Line 461

Line 343 -344 . ‘One aliquot was used to test for the presence or absence of antibodies of Rift Valley Fever (RVF) and Peste de Petits Ruminants (PPR) antibodies according to the objective of the STSD project’ Give some explanation about this work and make clear that the present FMD work is a part or accompany of that work.

Explained in Line 465-468

Line 363-63. Rewrite the sentence avoiding repetitions and put the right reference for the test kit (product, Manufacture Company and place/country).

Done in Line 488-492

Line 365-67 On the seropositivity/negativity to FMDV antibodies the outcome variables were categorised based on the on the results of the 3ABC blocking enzyme-linked immunosorbent assay.

Corrected in Line 492-495

Line 367-73. The test procedure is not clearly documented. Revise the English.

The procedure has been revised in Line 488-496. The details on the test procedure have been removed as advised by reviewer 2 (Line 497-513)

Line 390-94. Why was the herd level variables first entered to MS access (unlike the animal level variables which are directly entered to MS excel) before being brought to MS excel for data cleaning and coding?

Herd level variables were first entered into MS Access because of the large amount of data which needed to be compartmentalized in tables which could then be linked as appropriate (happens better in MS Access) before export to MS Excel for analysis as needed. Animal level variables were few and easy to enter into MS Excel in one sheet. Besides animal level data were in the sampling forms in the custody of the laboratory personnel while the herd level data were in questionnaires in the custody of data entry personnel in the epidemiology department. Entering the data separately saved time as one did not have to wait for the other. Linking the two data sets after entry was easy. See Line 524-525

Line 402- To do this you need to document the se and sp of the test in the laboratory diagnosis section.

Done in Line 492

Line 403- 433 statistical analysis part has lot of repetition and unnecessary detail. For example line 405-6 has the same idea with line 402-405 both of them are about crude association using chi-square.

Chi-square is used i) to test differences in proportions and ii) to test crude associations. The statement in Line 403-5 is about testing the difference in proportions and has been retained while that in Line405-6 is about testing the crude association between FMD sero-positivity and potential risk factors and has been removed in accordance with the general comments of the authors. The statistical analysis has been streamlined. See Line 539-541.

But few lines down it mention bivariable analysis is done. The chi- square test of comparison and bivariable analysis are the same and the chi-square is not needed for variables in considered in the bivariable logistic regressions

Removed as mentioned above

The terminology bivariable is not correct has to be changed into univariable. The common usage is univariable and multivariable. It about the number of independent variables. If only one independent variable is included it is univariable and if more than one indnepenet variables is included it is multivariable.

Corrected

Line 434-36 The results of our study have been presented mainly in tables and figures and interpreted in text. Although the bivariable regression was carried out for all risk factors (individual animal and herd level) together, the results are in two tables to avoid too large a table.

Sentences have been removed in Line 582-584

Other issues in this section;

- The purpose the univariable analysis should be mentioned.

Univariable analysis has been removed

- For goodness of it test, it is enough to mention what tests are used with appropriate reference.

Done in Line 571-573. How each test measures goodness of fit is unnecessary detail.

Unnecessary detail removed in Line 573-581

- In several places in this part the word’ interpretation’ is incorrectly used. For example specifying confidence interval level and P- values (419-20) or putting results in text (line 434-35) are not interpretations. Interpretations ae given meaning for you findings that is done in the discussion.

Terms have been removed in Line 565-6 and 582-3.

Results

Line 450. In M&M, the number of herds sampled was stated as 323 herds* 2 strata = 646 so how the herd number increased to 898.

If one herd could yield all the animals required, only that herd was sampled, otherwise additional herds that were in contact with the selected herds were sampled until the required number to be sampled in the sub-location was reached as also mentioned in Line 435-437. See also Line 602-603.

Line 451. Mention why the remaining samples were not available for testing

Mentioned in Line 604-605

Line 472. However a large proportion ……

Corrected on Line 626

Line 482. Write in the full ideas instead of using “so” to make it clearer

Corrected on Line 636 and 637

Line 496. What is the difference between communal grazing and mixed grazing?

Explained in Line 655

Line 515-16. Sero-prevalence of a total of 7564 sera from the whole country was determined for the

presence of non-structural FMDV protein (antibodies).

Corrected on Line 671-673

Line 517. “Prevalence rate” Prevalence is not rate. Simply use prevalence (which known to be proportion). Correct this throughout the document.

Corrected throughout the document

Line 518. if χ2 has to be reported it has to include the degrees of freedom like χ2(3), which means χ2 at 3 degrees of freedom. Do this throughout the manuscript

Where chi-square test is for comparison of two proportions at a time as in this case, the degree of freedom is 1 and is usually not reported. The results of chi-square test for test of crude association where the degrees of freedom are higher have been removed from the manuscript as per the reviewer recommendations.

Line 516. Write it as apparent prevalence as you have also true prevalence estimate

Corrected on Line 673

Line 527. ‘Showed seronegativity’ is not good expression; state that prevalence in these counties is zero

Corrected on Line 684-685

Line 530. Put the estimated true Seroprevalence in figure.

Inserted in Line 687

Line 531-535. What does samplings sites represent, villages, individual herds or what? the map in figure 3 does not provide any information except the distribution of sampling sites. It should have indicate the negative sites as well. Moreover the legend and labels in the maps are not visible.

Figure 3 has been removed. Explanation is now only in text in Line 689-691

Line 539 PAIR WISE Pearson correlation…………

Corrected on Line 785

Line 539 …‘between county and production zone”….. No risk factor variable called ‘county type’ was mentioned in the list of variables indicated M&M part. Included in L524

Moreover test of collinearity is needed for the multivariable analysis. So this sentence should go down where multivariable results are documented.

Inserted in Line 785-788

Another issue here is the use of the term ‘risk factor” should be replaced by “potential risk factor”. The variables are hypothesized to be a risk factor, not yet confirmed to be risk factor. They will be risk factor when they are found so after the analysis. So they should be referred to as potential risk factors thought out the document until they are confirmed.

Done throughout the document.

Line 546-47. Where is the result of the statistical analysis i.e. P-value

Provided on Line 705-6

Line 546-53. In this section it seems χ2 is used but in chi-square for comparison of three or more groups, it tells you only whether there is significant difference in the proportion/ prevalence among all groups. It doesn’t tell you between which pairs is the difference significant. So how can you come up with this results where the variables has three categories like breed (exotic, local, cross)?

The comparisons were of two categories at any time like local with cross-breed; local with exotic; cross-breed with exotic and not all three at the same time.

Line 554. Replace ‘the between herd prevalence’ with ‘herd level prevalence”

Done in Line 712

Line 564. If it is not significant, why is it surprising? In the first place, in the result section just put what you find; such interpretation should be reserved for the discussion

Corrected on Line 772

Line 566-71. The same comment as above in line 546-53.

Same explanation holds as for Line 546-53

Line 604- 5. The result emphasis should be which factors are significantly associated with FMD seropositivty. Whether the association is positive or negative depends how the data was coded during analysis. For example, it is not sex that is negatively associated but it is being maleness.

Corrected in Line 813-828

Line 604. Instead of table 5, S4 and S5 should be part of the main manuscript not supplementary.

All these tables have been removed from the manuscript.

Line 612. S5 table attached is not about the herd level variables. Check whether the attached table is the right one.

Table has been removed altogether

Line 612-13. The comparator should be mentioned.

The analysis has been removed

Line 627-8. The purpose of univaraible analysis is to screen the potential risk factors. If cut off p-value 0.2 does not reduce them small cut off should have been used. Actually given the very large sample size there was no need to screen in this study and univaraible analysis was not necessary.

Univariable analysis removed

Line 645-76. Repetition of the table. Enough to mention the most salient results and leave the remaining detail to be referred from table

Corrected

Discussion

Line 685. Delete ‘It is true’ and start with ‘According to this study …..’

Corrected on Line 870

Line 724-30. For SR age of 6 months and above can be considered as matured as they can be bred at this age and classification of mature above 1years of age is not appropriate. Hence it difficult to think these age animals (age 6 months – 1 year) will be kept at homestead and are less exposed to the disease.

Under Kenyan conditions, SR under one year are still not mature and are rarely bred. They remain close to the homestead or are grazed separate from the main herd.

The observed higher prevalence in older animals could also be due cumulative seropositivity through repeated infection in their longer life time.

Included in the discussion L917-918

Line 730. Conversely

Corrected on Line 920

Line 731. ‘Female posted’ change the word ‘posted’ with other more appropriate word

Corrected on Line 921

Line 730-32. Both the univariable and the multivariable analysis showed females have significantly higher prevalence than males. Which result is being discussed here!

Corrected on Line 920-923

Line 740 ‘….position…’ to mean explanation?

Removed

Line 745. Change the word ‘contrary’ with the actual type purchase it self

Removed

Line 749-50. not clear

Removed

Line 755-59. Make it clearer

Clarified on Line 945-952

Line 768. … three..

Removed

Line 784-95. Merge this discussion with preceding paragraphs. In the first place, what should be discussed is the result of the final model where confounding is controlled. It is meaningless to discuss the crude results of the chi-square or univariable analysis as these can’t correctly identify significant risk factors because of confounding. So the discussion in the preceding paragraphs should be adjusted accordingly.

Done

Conclusion

Line 820-21. “The findings of this study give an understanding of the potential role of small ruminants in the epidemiology of FMD in Kenya and contribute to the global scenario’ Not exactly. It is difficult to say anything about the role of SR in epidemiology of FMD based on this study.

Corrected in Line 1013-16

Line 824-25. You found high Seroprevalence does not confirm that they transmit and maintain the disease. So this conclusion cannot be warranted based on your findings.

Revised on line 1020

Line 826. “Cross contamination” has to be replaced with cross transmission

Replaced in Line 1021

Line 827. ‘This outlays’?

Corrected on Line 1022

Line 829 ..”post”.. ??

Corrected on Line 1024

Figures

The legends and labels of all figures (fig.1,2,3) are not visible

Fig. 1 and 3 have been removed and fig. 2 has been improved.

Reviewer #2: This study aims to determine the seroprevalence of FMD in small ruminants and determine the risk factors associated. This is an original, highly useful study that may be utilised to further understand the epidemiology of FMD transmission in Kenya.

The manuscript is very thorough, however is much too long, particularly the introduction. The whole manuscript needs to be made more concise, as there is a lot of repetition throughout, between sections, between the text and figures, and between figures. Some tables could be merged, with some columns removed – for example tables 3 and S4. The current layout makes it more confusing to the reader than it needs to be – as this is a simple study approach with good results. However, the message seems to get lost in the length of the manuscript.

For the introduction, only information relevant to the study should be included, for example detail on molecular tests and differential diagnosis is not required – potentially only mentioned. Much of the information is or could be included in the discussion if it is necessary. Additionally, please ensure that you include references where appropriate, there are multiple sections where there are not enough references.

The methods section is very repetitive, particularly regarding the description of the number of counties, and the data analysis section could be much more concise. Additionally, the ELISA method does not need to be described in such detail as it is a commonly used test.

In the results section, please ensure that your subheadings accurately reflect what is included within them and avoid repetition between tables and the text. Additionally, are chi-squared test required if regression has been done? Or can this be more concisely displayed e.g. all in one table? At the moment it is very difficult to flip between all of the tables and the lengthy text to work out the results.

Additionally, I would like to see in the descriptive analysis the number of animals that were vaccinated for FMD and that had clinical signs (even if it was 0). This is very important information when investigating seroprevalence. Particularly when the vaccines administered in Kenya are often not of high quality and may induce NSP antibodies – this should also be mentioned in the discussion.

Additionally, please be careful with capitalised words that do not need to be, for example ‘county’ and directions (east/west etc.)

Consequently I recommend major revisions to this manuscript to make it more 'reader friendly'. We appreciate the compliments regarding the study usefulness and thoroughness. The introduction has been shortened and irrelevancies removed. Repetitions have also been removed. S4 has been removed. Description of the ELISA method has been summarized. Chis-quare test of crude association results have been removed. In Kenya sheep and goats are not vaccinated against FMD as indicated in Line138 and 1015-16 No clinical signs were encountered during the survey as indicated now in Line 671. Unnecessary capitalization of words has been removed.

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Jagadeesh Bayry

7 Apr 2021

PONE-D-20-15166R1

Epidemiological study on foot-and-mouth disease in small ruminants: sero-prevalence and risk factor assessment in Kenya

PLOS ONE

Dear Dr. Kairu-Wanyoike,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

Overall revision was satisfactory. Both the reviewers have identified several minor points that we request you to consider for the revision.

==============================

Please submit your revised manuscript by May 22 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Jagadeesh Bayry, DVM, PhD, HDR

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: (No Response)

Reviewer #2: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Comments to authors

General comments.

The manuscript has been considerably improved by the authors following the first round of comments. However, there are some issues remaining to be resolved. They are detailed below.

Note. The line numbers were not working in many cases. This made difficult to trace the corrections and has to be corrected in the next versions.

Introduction

Line 134. What have found to be the role of small ruminant in the epidemiology of FMD? Are they carrier transmitter, spill over hosts, primary host which can maintain the disease by themselves irrespective the presence of cattle or what? I don’t think the scope of the work can lead to these types of conclusions.

Material and methods

Line 184. A herd…..

Line 187. Instead of the software, provide reference for methodology of the sample size determination. Moreover, the website. http://www.promesa.co.nzl seems not working. check it.

Line 188. ‘expected between herd prevalence 30%” what does it mean and how is the 30% determined?

Line 190. Where did your get the intracluster correlation is 0.2?

Line 193. “Prevalence in a herd is 20%”. Give reference from where did you get this?

Generally, as which sample size formula is used is not mentioned, it is difficult to understand how sample size was determined.

Line 198 . remove” Because it was one village per sub-location and one herd per village, it is appropriate to use the terms interchangeably” as it is confusing which terms it refers, and it also adds no clarity.

Line 224-227. multistage sampling; sublocation, village, herd and then individual animals. Compare this with your description in line 181-183.

Line 308. (Pearson?) correlation coefficient of 0.3 threshold for collinearity is highly conservative. Are there any references for this?

Multicollinearity would have been more appropriate than simple collinearity.

Results

Line 334. Herd was defined better in M& M and not needed here.

Line 344. design effect for 2 may not be high for FMD as it id highly transmitted within a herd and could result high clustering effect.

Line 403. “None of the herds surveyed had animals that showed FMD signs” . this should be qualified as at the time of sampling.

Line 447. What are you doing in the above two tables? were you not assessing association of risk factors for SR FMD? When you say FMD seropositivity was higher in adult than young, don’t you mean age is a risk factor?! So the above analysis a univariable (crude) risk factor analysis and should come under risk factors analysis title. Actually, I don’t see its importance as far as you do the multivariable analysis as in table 5. After all the definitive test for risk factor is the multivariable test. This has been commented in the previous version.

Line 489. Table 5. This is the final model. Then why was the non-significant factors such as Brought in SR, SR breeding method, elevation included in the final model. In the methodology it was mentioned backward fitting (selection?) was used. If that is the case, in backward selection at each iteration the non-significant variables are removed until only significant factors and confounding factors remain in the final model.

Line 513. The interpretation for interaction is not clear. After the doing the interaction I would expect results such as: maleness and adultness interact positively and increased risk of FMD more than either of maleness or adultness alone.

Discussion

Line 534. Across the categories

Line 583-684. Any evidence about subclinical infection SR to conclude this?

Conclusion

Line 600. What is this role?

Line 600 -604 your result could not give any clue about potential transmission of FMD between cattle and sheep let alone sheep as reservoir of infection for cattle. Is it not possible SR are getting infection from cattle? It is known that cattle are more susceptible to FMD and are often the maintenance hosts for FMD viruses except SAT viruses where African buffalo are involved. Cattle tend to be carrier longer and only short period of carrier was reported for SR.

This comment has been given in previous version as well but not has not been corrected. So should be corrected or need convincing explanation.

Reviewer #2: The authors have done a good job in working on the previous reviewer’s comments. Unfortunately, it seems some of my specific comments from review round 1 were not sent forward to the authors and therefore some that have not already addressed are repeated here again below.

Although the manuscript has been shortened, I still think there is a requirement to further make the introduction and results more concise, which will make the study more pleasurable to read, as the results are good. I think there are options for tables to be combined and the number of columns reduced so that the important results do not get lost (see specific comments below).

Additionally, from what I can see there is no description as to what S2 file 1 represents and therefore I think it should be removed.

Specific comments

Abstract

Line 31-32 – No need to capitalise ‘non-structural proteins’. And remove the second full stop after ‘kit’.

Line 37 – Please provide the p number – not just say that it is was less than 0.05. Also, I think just the p value is enough, no need to include X2 value). However, I think there is no need to include this sentence (‘Sero-positivity was significantly……..p<0.05)’, as you have stated below that the sedentary production zone was negatively associated with seropositivity (line 40-41).

Introduction

Needs shortening further and moving a few things around to make more concise. A focus on Kenya and small ruminants is recommended.

Line 72 – I do not think there is a need for Table 1. Or if so it should be included in the supplementary files. I think a short sentence about FMD prevalence on other East African countries would be enough here.

Lines 66-70 – Suggest removing this short paragraph, and instead mentioning seroprevalence studies of FMD in small ruminants in other East African countries.

Lines 75-108 – suggest reducing this further to make the introduction more concise. I think the most important thing to mention is FMD in small ruminants. (serotypes in Kenya are already mentioned below so no need to mention here?)

Lines 109-119 – Suggest removing this paragraph.

Lines 124 – 127 – Suggest removing these two sentences (‘Vaccination programmes…….maternal immunity’).

Lines 135 – 137 – suggest removing this sentence (‘This is because…..borders’).

Methods

Lines 151-158 – I think that this paragraph can be removed?

Line 161 – Add a full stop after ‘country’.

Figure 1 – I’m not sure if it is just the version that is attached to this PDF, but please ensure Figure 1 is clear, as the version I can see is blurred.

Lines 183 – 184 – Suggest removing these sentences (‘The total sample……strata’). Also suggest using the term zone instead of strata going forward.

Line 184 – please do not capitalise the word ‘herd’.

Line 188-189 – please state why a 30% expected between herd prevalence was used, and in line 193, why an expected prevalence of FMD in the herd of 20% was used. What information was this based on?

Lines 214-216 – suggest removing these two first sentences as this information has already been described previously.

Line 218 – change to ‘these WERE used…’

Line 279 – 280 – Were two different ELISA tests performed or is the ‘3ABC blocking enzyme-linked immunosorbent assay’ the same as the ‘3 ABC- ELISA ID Screen®FMD NSP Competition kit’. I assume they are the same, but I think it is confusing here. Maybe it is best to say in line 275 that ‘Individual animal serum samples were analysed……’ and then remove the sentence in line 279-280 (‘At individual level……assay’).

Line 287 – I do not think S2 file should be included – it is not very self-explanatory, and all of the data are in the other supplementary files.

Line 295 – What does this refer to? ‘--“Bunny-Wunnies Freak Out”’? Please remove.

Results

Line 340 – Please do not capitalise ‘counties’

Lines 341-345 – Suggest moving this sentence and reasoning to the discussion.

Suggest removing Table 2, as the important information is displayed in the other tables. Move to supplementary data if necessary to keep it. I am not sure what the column ‘sum’ refers to in Table 2. Is this table referring to the herd sizes that animals were sampled from, or the animals sampled?

Lines 355-398 – This section needs to be made more concise – suggest reducing to one paragraph. If the Table is brought to the main article instead of supplementary, only a short summary of results is required.

Lines 403-405 – Please improve the English language of this sentence.

I’m not sure that confidence intervals are required for apparent sero-prevalence – only for true prevalence.

Table 3 – remove variable code. Suggest to remove the ‘negative’ column. Suggest adding p value column for each variable in Table 3 for chi squared test. Then the reader can clearly see the results without hunting through the text.

Table 4 – remove variable code. Suggest to remove the ‘negative’ column. Suggest adding p value column for each variable in Table 4 for chi-squared test. Then the reader can clearly see the results without hunting through the text.

Can Tables 3 and 4 be combined?

Lines 403-474 – Remove ꭓ2 values from the text and only include p values. Also this section needs to be made more concise. Including the p values for the chi-squared tests in Tables 3 and 4 would mean less description is required.

Line 479 – Do ‘all the potential risk factors’ mean all of those in Tables 3 and 4? Please be clear.

Table 5 – Combine with Table 6? There are too many unnecessary columns. Suggest removing the columns B, Se/S.E. and Z ratio.

Discussion

Line 534 – ‘categories’ is spelled incorrectly.

Line 541 – change ‘FMD outbreak peaks is…’ to ‘FMD outbreaks are associated…’.

Line 545 – Although foot and mouth disease is spread by contact, I would recommend changing this sentence as other methods of transmission are also common e.g. fomites/aerosol. It is more likely that as herd are closer together there are more chances for the virus to spread?

Line 581 – ‘transmission’ is spelled incorrectly.

Suggestion to include a discussion about the limitation of the study that testing was not done for circulating virus (e.g. virus isolation/PCR), and therefore it is unknown when these animals became infected. Indeed, further investigations (potentially using the same samples) could be done and also to identify the serotypes that the SR were infected with using serotype specific ELISAs.

Line 606 – Remove double word ‘cross’.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Aug 2;16(8):e0234286. doi: 10.1371/journal.pone.0234286.r004

Author response to Decision Letter 1


5 Jul 2021

We are sincerely grateful to both Reviewers for the valuable comments and suggetions that have helped us improve the manuscript and sharpen our writing skills. Below are our responses to the comments by the reviewers.

Reviewer #1: Comments to authors

General comments.

The manuscript has been considerably improved by the authors following the first round of comments. However, there are some issues remaining to be resolved. They are detailed below.

Note. The line numbers were not working in many cases. This made difficult to trace the corrections and has to be corrected in the next versions.

Thank you for the compliment. We apologize for the hardship faced in tracing corrections. In this revision, reference is made to the line numbers in the revised manuscript with track changes for ease of traceability. However the line numbers in the manuscript with accepted changes may be quite different because deleted lines in the revised manuscript with track changes remain while deleted lines in the manuscript with accepted changes disappear.

Introduction

Line 134. What have found to be the role of small ruminant in the epidemiology of FMD? Are they carrier transmitter, spill over hosts, primary host which can maintain the disease by themselves irrespective the presence of cattle or what? I don’t think the scope of the work can lead to these types of conclusions.

Statement has been removed in L139-143.

Material and methods

Line 184. A herd…..

Done on line 190.

Line 187. Instead of the software, provide reference for methodology of the sample size determination. Moreover, the website. http://www.promesa.co.nzl seems not working. check it.

Reference for formula used provided on Line 193.

Line 188. ‘expected between herd prevalence 30%” what does it mean and how is the 30% determined?

Corrected and reference provided on Line 196.

Line 190. Where did your get the intracluster correlation is 0.2?

Corrected and reference provided on Line 197.

Line 193. “Prevalence in a herd is 20%”. Give reference from where did you get this?

Reference provided on Line 203.

Generally, as which sample size formula is used is not mentioned, it is difficult to understand how sample size was determined.

Provided in Line 200-205.

Line 198. remove” Because it was one village per sub-location and one herd per village, it is appropriate to use the terms interchangeably” as it is confusing which terms it refers, and it also adds no clarity.

Removed in Line 209-210.

Line 224-227. multistage sampling; sublocation, village, herd and then individual animals. Compare this with your description in line 181-183.

Content of Line 224-227 has been removed in Line 236-238 to avoid confusion.

Line 308. (Pearson?) correlation coefficient of 0.3 threshold for collinearity is highly conservative. Are there any references for this?

Multicollinearity would have been more appropriate than simple collinearity.

It is acceptable to measure multicollinearity by the variance inflation factor (VIF) for continuous data or Spearman correlation for categorical data. Our data being mainly categorical could not utilize the VIF method. Reference [54] for correlation coefficient threshold is offered in Line 327.

Results

Line 334. Herd was defined better in M& M and not needed here.

Removed in Line 353.

Line 344. design effect for 2 may not be high for FMD as it id highly transmitted within a herd and could result high clustering effect.

Corrected to ‘sufficient’ on Line 611.

Line 403. “None of the herds surveyed had animals that showed FMD signs”. This should be qualified as at the time of sampling.

Done in Line 447-448.

Line 447. What are you doing in the above two tables? Were you not assessing association of risk factors for SR FMD? When you say FMD sero-positivity was higher in adult than young, don’t you mean age is a risk factor?! So the above analysis a univariable (crude) risk factor analysis and should come under risk factors analysis title. Actually, I don’t see its importance as far as you do the multivariable analysis as in table 5. After all the definitive test for risk factor is the multivariable test. This has been commented in the previous version.

The study is not just about association. It is important to know what the sero-positivities were across the categories with or without association and then find the association with the potential risk factors as the title indicates. It is acceptable to compare proportions without necessarily establishing association and strength of association with independent variables but in our study we have done both according to our objective.

Line 489. Table 5. This is the final model. Then why was the non-significant factors such as Brought in SR, SR breeding method, elevation included in the final model. In the methodology it was mentioned backward fitting (selection?) was used. If that is the case, in backward selection at each iteration the non-significant variables are removed until only significant factors and confounding factors remain in the final model.

The most parsimonious model together with interactions/contrasts has now been presented in Table 5.

Line 513. The interpretation for interaction is not clear. After the doing the interaction I would expect results such as: maleness and adultness interact positively and increased risk of FMD more than either of maleness or adultness alone.

This has been clarified in Line 585 to 591.

Discussion

Line 534. Across the categories.

Corrected in Line 676.

Line 583-684. Any evidence about subclinical infection SR to conclude this?

Do you mean Line 583-584?

Sentence has been removed in Line 683-687.

Conclusion

Line 600. What is this role?

Line 600 -604 your result could not give any clue about potential transmission of FMD between cattle and sheep let alone sheep as reservoir of infection for cattle. Is it not possible SR are getting infection from cattle? It is known that cattle are more susceptible to FMD and are often the maintenance hosts for FMD viruses except SAT viruses where African buffalo are involved. Cattle tend to be carrier longer and only short period of carrier was reported for SR.

This comment has been given in previous version as well but not has not been corrected. So should be corrected or need convincing explanation.

The content of these lines has been recast in the revised manuscript and unjustified assertions removed.

Reviewer #2: The authors have done a good job in working on the previous reviewer’s comments.

Thank you for the compliment.

Unfortunately, it seems some of my specific comments from review round 1 were not sent forward to the authors and therefore some that have not already addressed are repeated here again below.

Although the manuscript has been shortened, I still think there is a requirement to further make the introduction and results more concise, which will make the study more pleasurable to read, as the results are good. I think there are options for tables to be combined and the number of columns reduced so that the important results do not get lost (see specific comments below).

Additionally, from what I can see there is no description as to what S2 file 1 represents and therefore I think it should be removed.

Specific comments

Abstract

Line 31-32 – No need to capitalise ‘non-structural proteins’. And remove the second full stop after ‘kit’.

Done in Line 32-33.

Line 37 – Please provide the p number – not just say that it is was less than 0.05. Also, I think just the p value is enough, no need to include X2 value). However, I think there is no need to include this sentence (‘Sero-positivity was significantly……..p<0.05)’, as you have stated below that the sedentary production zone was negatively associated with seropositivity (line 40-41).

Sentence has been removed in Line 36-37.

Introduction

Needs shortening further and moving a few things around to make more concise. A focus on Kenya and small ruminants is recommended.

Line 72 – I do not think there is a need for Table 1. Or if so it should be included in the supplementary files. I think a short sentence about FMD prevalence on other East African countries would be enough here.

Table 1 taken out to be supplementary and sentence on prevalence of FMD in East African countries inserted in Line 71-75.

Lines 66-70 – Suggest removing this short paragraph, and instead mentioning seroprevalence studies of FMD in small ruminants in other East African countries.

Removed in Line 66-68 and summary sentence on sero-prevalence studies in East African countries inserted in Line 71-75.

Lines 75-108 – suggest reducing this further to make the introduction more concise. I think the most important thing to mention is FMD in small ruminants. (serotypes in Kenya are already mentioned below so no need to mention here?)

Removed in Line 89-92.

Lines 109-119 – Suggest removing this paragraph.

Removed in Line 115-126.

Lines 124 – 127 – Suggest removing these two sentences (‘Vaccination programmes…….maternal immunity’).

Removed in Line 130-133.

Lines 135 – 137 – suggest removing this sentence (‘This is because…..borders’).

Removed in Line 141-143.

Methods

Lines 151-158 – I think that this paragraph can be removed?

Removed in Line 157-164.

Line 161 – Add a full stop after ‘country’.

Done in Line 167.

Figure 1 – I’m not sure if it is just the version that is attached to this PDF, but please ensure Figure 1 is clear, as the version I can see is blurred.

I think it is the pdf version that is blurred.

Lines 183 – 184 – Suggest removing these sentences (‘The total sample……strata’). Also suggest using the term zone instead of strata going forward.

Done in Line 189-190. Zone applied instead of strata going forward.

Line 184 – please do not capitalise the word ‘herd’.

Done in Line 190.

Line 188-189 – please state why a 30% expected between herd prevalence was used, and in line 193, why an expected prevalence of FMD in the herd of 20% was used. What information was this based on?

Given in Line 196 and 203.

Lines 214-216 – suggest removing these two first sentences as this information has already been described previously.

Removed in Line 209-210.

Line 218 – change to ‘these WERE used…’

The ‘WAS’ is referring to the sampling frame which is one and not the sub-locations and clarified accordingly on Line 229.

Line 279 – 280 – Were two different ELISA tests performed or is the ‘3ABC blocking enzyme-linked immunosorbent assay’ the same as the ‘3 ABC- ELISA ID Screen®FMD NSP Competition kit’. I assume they are the same, but I think it is confusing here. Maybe it is best to say in line 275 that ‘Individual animal serum samples were analysed……’ and then remove the sentence in line 279-280 (‘At individual level……assay’).

Done in Line 287/88 and Line 291-293.

Line 287 – I do not think S2 file should be included – it is not very self-explanatory, and all of the data are in the other supplementary files.

File has been removed in Line 300.

Line 295 – What does this refer to? ‘--“Bunny-Wunnies Freak Out”’? Please remove.

Removed in Line 309.

Results

Line 340 – Please do not capitalise ‘counties’

Corrected in Line 359/360.

Lines 341-345 – Suggest moving this sentence and reasoning to the discussion.

Moved to line 607-612.

Suggest removing Table 2, as the important information is displayed in the other tables. Move to supplementary data if necessary to keep it. I am not sure what the column ‘sum’ refers to in Table 2. Is this table referring to the herd sizes that animals were sampled from, or the animals sampled?

The term ‘sum’ refers to number of sheep and goats in the herds sampled in the study area as indicated in the title but the term has been revised in the table and the title has been made clearer. The data in this table is not in any other table and therefore cannot be removed but is now placed as supplementary table 2.

Lines 355-398 – This section needs to be made more concise – suggest reducing to one paragraph. If theTable is brought to the main article instead of supplementary, only a short summary of results is required.

There are two Tables in this text which have now been brought to the main article (Table 1 and 2) and summaries given (Line 376-379 and Line 391-399). The tables cannot be combined because it would result in too large a table.

Lines 403-405 – Please improve the English language of this sentence.

Done in Line 447-449.

I’m not sure that confidence intervals are required for apparent sero-prevalence – only for true prevalence.

Because of the near perfection of the tests (Se=100%); Sp=99%). Calculation of the CIs of true prevalence p±1.96√(pq/(nJ^2 )) is equivalent to that of simple proportion p±1.96√pq/n as J (Se+Sp-1) nears 1. Thus CIs of true prevalence are similar to those of apparent prevalence and have been applied to the section in line 450-465.

Table 3 – Remove variable code. Suggest to remove the ‘negative’ column. Suggest adding p value column for each variable in Table 3 for chi squared test. Then the reader can clearly see the results without hunting through the text.

Table 4 – remove variable code. Suggest to remove the ‘negative’ column. Suggest adding p value column for each variable in Table 4 for chi-squared test. Then the reader can clearly see the results without hunting through the text.

In Table 3 and 4. Done for overall chi-square for each variable but for those with more than two categories, pairwise chi-square results have been given in the text as they cannot be included in the tables.

Can Tables 3 and 4 be combined?

No because combining them will create too large a table.

Lines 403-474 – Remove ?2 values from the text and only include p values. Also this section needs to be made more concise. Including the p values for the chi-squared tests in Tables 3 and 4 would mean less description is required. Done. However, for pairwise comparisons, chi-square remain in the text as they cannot be expressed in the Tables.

Line 479 – Do ‘all the potential risk factors’ mean all of those in Tables 3 and 4? Please be clear.

Clarified in Line 553.

Table 5 – Combine with Table 6? There are too many unnecessary columns. Suggest removing the columns B, Se/S.E. and Z ratio.

Table 5 combined with Table 6 and corrections made as suggested.

Discussion

Line 534 – ‘categories’ is spelled incorrectly.

Corrected in line 676.

Line 541 – change ‘FMD outbreak peaks is…’ to ‘FMD outbreaks are associated…’.

Corrected on Line 631.

Line 545 – Although foot and mouth disease is spread by contact, I would recommend changing this sentence as other methods of transmission are also common e.g. fomites/aerosol. It is more likely that as herd are closer together there are more chances for the virus to spread?

Corrected on Line 635-636.

Line 581 – ‘transmission’ is spelled incorrectly.

Corrected in Line 683.

Suggestion to include a discussion about the limitation of the study that testing was not done for circulating virus (e.g. virus isolation/PCR), and therefore it is unknown when these animals became infected. Indeed, further investigations (potentially using the same samples) could be done and also to identify the serotypes that the SR were infected with using serotype specific ELISAs.

Included in line 702-712.

Line 606 – Remove double word ‘cross’.

Removed in line 728.

________________________________________

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Attachment

Submitted filename: Response to reviewer comments PONE-S-20-18913R1 SR FMD.docx

Decision Letter 2

Jagadeesh Bayry

8 Jul 2021

Epidemiological study on foot-and-mouth disease in small ruminants: sero-prevalence and risk factor assessment in Kenya

PONE-D-20-15166R2

Dear Dr. Kairu-Wanyoike,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Jagadeesh Bayry, DVM, PhD, HDR

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Jagadeesh Bayry

22 Jul 2021

PONE-D-20-15166R2

Epidemiological study on foot-and-mouth disease in small ruminants: sero-prevalence and risk factor assessment in Kenya

Dear Dr. Kairu-Wanyoike:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Jagadeesh Bayry

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. FMD sero-prevalence and associated risk factors in SR in various countries.

    (DOCX)

    S2 Table. Number of sheep and goats in the herds sampled in the study area, Kenya, 2016.

    (DOCX)

    S3 Table. Small ruminant FMD sero-positivity per county, Kenya, 2016.

    (DOCX)

    S1 File. Data collection tools.

    (DOCX)

    Attachment

    Submitted filename: Response to Reviewers.docx

    Attachment

    Submitted filename: Response to reviewer comments PONE-S-20-18913R1 SR FMD.docx

    Data Availability Statement

    All relevant data are within the manuscript and its S1 File, S1S3 Tables files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES